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Over 50% of global lung cancer incidence occurs in less developed 
regions (LDRs).  Despite this, little is known regarding lung cancer risk factors in 
LDRs such as Nepal. Using data from a hospital-based case-control study 
conducted in B. P. Koirala Memorial Cancer Hospital (Nepal, 2009-2012), 
relationships between reproductive and hormonal factors and lung cancer were 
examined among women aged 23-85 years. Odds ratios (ORs) and 95% 
confidence intervals (CIs) were calculated using multivariable logistic regression. 
Among postmenopausal women, those with a younger age at menopause 
(<45years; 45-49years) had an increased odds of lung cancer compared to those 
with an older (≥50years) age at menopause (OR=2.14, 95%CI=1.09, 4.17; 
OR=1.93, 95%CI=1.07, 3.51, respectively), after adjusting for age and 
cumulative active smoking. This is the first study to characterize these 
relationships among Nepali women. Further research is needed to elucidate the 
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1.1 Background of the Study 
Lung cancer is the most commonly diagnosed cancer and the primary 
cause of cancer mortality worldwide1-4. Approximately 58% of the global lung 
cancer incidence and 60% of the global lung cancer mortality, in 2012, occurred 
in less developed regions (LDRs) 4, which include all regions of Africa, Asia 
(excluding Japan), Latin America and the Caribbean, Melanesia, Micronesia and 
Polynesia5.   These figures are only expected to increase in the next decade.  
However, epidemiologic data on the risk factors of lung cancer in LDRs such as 
Nepal is still scarce. 
Several studies conducted in more developed regions, which include 
Europe, Northern America, Australia, New Zealand and Japan5, have suggested 
potential gender differences in risk6-10. Some investigators have reported that 
women may be more susceptible to the carcinogenic effects of tobacco6-8 and 
that they represent a higher proportion of non-smoking lung cancer patients9, as 
compared to men. Kiyohara et al. reviewed the existing literature on gender and 
lung cancer susceptibility in 2010 and concluded that women may have a greater 
risk of lung cancer for a given level of tobacco smoke exposure10. Thus, the risk 
of developing lung cancer may vary by gender. 
The differential distribution of histological subtypes by gender11 and the 
presence of specific hormone receptors on lung cancer cells12 support a role for 
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reproductive and hormonal factors in the development of lung cancer. Lung 
cancer in women is more likely to be classified as adenocarcinoma, whereas 
among men, squamous cell carcinoma is more commonly diagnosed11. In 
addition, female sex-hormone receptors (estrogen-β and progesterone receptors) 
have been found on human lung cancer cells12. According to Omoto and 
colleagues, adenocarcinomas exhibited significantly higher expression of 
estrogen-β receptors than squamous cell carcinomas13.  Stabile et al. observed 
that incubation of lung cancer-derived cell lines with β-estradiol significantly 
increased cellular proliferation and that anti-estrogens or estrogen antagonists 
inhibited this proliferation, suggesting that estrogen could theoretically promote 
lung cancer14. Taken together, these results provide a mechanistic rationale to 
investigate the role of reproductive and hormonal factors in the development of 
lung cancer.  
While several studies have investigated the association between 
reproductive and hormonal factors and lung cancer in more developed regions of 
the world 15-30, no prior study has assessed this relationship in LDRs such as 
Nepal. Furthermore, the distributions of reproductive and hormonal 
characteristics have not been well characterized among Nepali women.   Given 
the increased lung cancer global burden in LDRs, the suggested higher 
susceptibility among women, and the above mentioned biological rationale, the 
relationship between reproductive and hormonal factors and lung cancer among 




1.2 Specific Aims  
The current study addresses the following specific aims: 
I. Primary Aim: To investigate reproductive and hormonal factors (such as age 
at menarche, age at menopause, menstrual duration, number of pregnancies 
or gravidity, age at first birth, age at first live-birth, and birth control use) in 
relation to lung cancer among Nepali women. 
Hypothesis: The odds of lung cancer among Nepali women will differ by 
reproductive and hormonal factors. More specifically, reproductive and 
hormonal factors, such as younger age at menarche, older age at 
menopause, longer menstrual duration, lower number of pregnancies or 
nulligravidity, older age at first birth, older age at first live-birth, and birth 
control use, will be associated with an increased odds of lung cancer. 
II. Secondary Aims: To examine if the relationship between reproductive and 
hormonal factors and lung cancer among Nepali women varies by smoking 
status. 
Hypothesis: The relationship between reproductive and hormonal factors and 
lung cancer will differ by smoking status.  
1.3 Significance of the Study 
According to the World Bank, Nepal is one of the poorest countries in the 
world31. In 2012, the country had an estimated total population of approximately 
27.5 million people, of which 25% were living under the national poverty line at 
that time32. Approximately 120 per 100,000 deaths are estimated to be due to 
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cancer in Nepal33. The B. P. Koirala Memorial Cancer Hospital (BPKMCH), which 
is the first national cancer center in Nepal, predicts that there are approximately 
35,000 to 40,000 prevalent cancer cases in Nepal33. However, Nepal’s national 
cancer control program is in its early stages of development and it may 
encounter major hindrances due to the scarcity of data on cancer risk factors 
among the Nepali populace34. 
In 2009, Pradhananga and colleagues compiled data from seven major 
cancer diagnostics and treatment hospitals to assess the cancer burden in 
Nepal, and reported that cervix uteri, breast and lung were the most cancer 
common sites among Nepali women35. Pradhananga et al. also noted that main 
cancer sites were different based on age groups, and that lung cancer was the 
number one cancer site for females seventy years old and above and the third 
most common cancer among Nepali women overall35. 
In summary, lung cancer is one of the three most common cancers among 
Nepali women. However, as aforementioned, research on the risk factors of lung 
cancer in a Nepali population is lacking. More specifically, the relationship 
between reproductive and hormonal factors and lung cancer among Nepali 
women has not been examined previously. Thus, the overall objective of the 
current research is to enhance the understanding of the underlying risk factors 





1.4 Literature Review 
Several epidemiological studies in more developed regions have 
investigated the role of female reproductive and hormonal factors in the 
development of lung cancer15-30. These studies have reported mixed findings on 
the association of lung cancer with reproductive and hormonal factors such as 
parity15-23, 25, 27, 29-30, gravidity21, age at first pregnancy21, 29, age at first birth15-21, 23, 
25, 30, age at menarche15-19, 21-23, 25, 29-30,  age at menopause15-19, 21-23, 29-30,  use of 
oral contraceptives16-19, 22-23, 25, 27, 29, duration of oral contraceptive use16-19, 22, 25, 
27, 29, and use of post-menopausal hormones16-19, 22-27, 29.  
Overall, a majority of the large prospective cohort studies have observed 
an inverse association between age at menopause and lung cancer17, 19, 23. In a 
prospective analysis of the NIH-AARP Diet and Health study cohort with 
approximately 185,000 women who were ages 50-71 years, the investigators 
found that age at natural menopause was inversely associated with lung cancer 
risk17. After stratifying by smoking status, this significant inverse relationship was 
observed only among former and current smokers17. Similarly, Baik et al. 19 and 
Weiss et al. 23 reported an increased risk of lung cancer among postmenopausal 
women with younger age at menopause, among the participants of the Nurses’ 
Health Study19 and the Shanghai Women’s Health Study cohort23, respectively. 
Although several studies have found an inverse association between 
parity and lung cancer15-16, 18, 20, 22-23, two recent large prospective cohort studies, 
by Brinton et al. 17 and Baik et al. 19, have reported null associations between 
parity and lung cancer. Similarly, the majority of studies have reported a null 
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association between lung cancer and the other reproductive and hormonal 
factors, such as age at first birth15-16, 18, 20-21, 23, 30, age at menarche15-16, 18-19, 21-23, 
25, 29,  use of oral contraceptives16-19, 22-23, 25, 27, duration of oral contraceptive 
use16-18, 22, 25, 27, 29 , and use of post-menopausal hormones16-19, 22-23, 27. 
A detailed review of these studies and their findings, with respect to the 



















2.1 Case – Control Study Design 
This ancillary study utilizes data from a hospital-based case-control study, 
which was conducted between November 2009 and December 2012, at the B. P. 
Koirala Memorial Cancer Hospital (BPKMCH) in the city of Bharatpur, Chitwan 
district34. The BPKMCH is the primary cancer referral center in Nepal.  About 606 
lung cancer cases and 606 frequency-matched controls, based on age (±5 
years), sex, ethnicity and residential area (district), were recruited for the main 
study. Lung cancer was defined according the International Classification of 
Diseases for Oncology, 2nd Edition (ICD-O2) codes C33 (trachea) and C34 
(bronchus and lung). The follow inclusion and exclusion criteria, and data 
collection methodology were used during the primary study. 
Inclusion Criteria: Eligible cases included patients diagnosed with primary lung 
cancer at the BPKMCH.  
Eligible controls included visitors (family and friends) of the non-lung cancer 
patients, subjects being screened for cancer and subjects accompanying the 
person being screened, at the BPKMCH hospital during the study period. 
Exclusion Criteria: Lung cancer patients were excluded if they were younger than 
18 years of age or if they were not residents of Nepal for at least 5 years prior to 
the study. False positive cases were excluded from the study, once histological, 
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cytological or X-ray-based diagnoses were performed.  Family members of the 
lung-cancer patient were ineligible to participate as controls. 
Data collection: All eligible participants were interviewed in-person by a trained 
staff member (nurse), who collected detailed information on tobacco and alcohol 
consumption, occupational history, reproductive and hormonal factors, medical 
conditions, family history of cancer, dietary habits and other lifestyle factors using 
a standardized questionnaire.  Information from all eligible cases was collected 
as soon as possible after initial lung cancer diagnosis in order to ensure minimal 
loss of cases due to death. A target interval of one day and a maximal interval of 
three months between diagnosis and recruitment were used for data attainment. 
Informed consent was obtained from the patient and their physician prior to data 
collection. 
2.2 Analytic Population 
For the present research, cases were defined as primary incidence of lung 
cancer diagnosed at the B. P. Koirala Memorial Cancer Hospital between 2009 
and 2012. The main case-control study consisted of 268 female lung cancer 
cases and 226 frequency-matched hospital-based controls. One lung cancer 
case was excluded from the current analysis due to a previous diagnosis of 
breast cancer (prior to the lung cancer diagnosis). Thus, the final analytic 





2.3 Dependent Variable 
Lung cancer was the primary outcome of interest. As aforementioned, the 
primary case-control study classified lung cancer based on the ICD-O2 codes 
C33 and C34. False positive cases, which were estimated to be around ten to 
twenty percent, were excluded from the study after final diagnosis. Final lung 
cancer diagnosis of eligible cases was confirmed by a histological, cytological or 
X-ray-based diagnosis.  For the current analysis, lung cancer was classified as 
“yes” (cases) or “no” (controls). 
2.4 Independent Variables 
The main exposures of interest consisted of reproductive and hormonal 
factors such as: 
Menopausal status: Classified as “pre-menopausal”, “post-menopausal” or 
“unknown”.  Pre-menopausal women were defined as those who reported still 
menstruating, at the time of questionnaire completion. Post-menopausal women 
were defined as those who reported to have stopped menstruating. 
Age at menarche: Defined as the age at which the participant reported having 
her first menstrual period (continuous measure). For the current study, this 
variable was analyzed as a continuous as well as a categorical variable. 
Categories such as <14, 14 and ≥15 years of age were formed, based on the 




Age at menopause: Defined as the age at which the participant reported having 
her last menstrual period (continuous measure). The present study evaluated this 
variable as a continuous and a categorical variable, among women who self-
reported being post-menopausal. Categories such as <45, 45-49 and ≥50 years 
of age were used, which were based on the variable distribution among the 
controls; missing values were categorized as “unknown”. 
Menstrual Duration: Defined as the difference between the participant’s reported 
age at menarche and age at menopause. Menstrual duration was examined as a 
continuous variable, among post-menopausal women (defined above).  
Number of Pregnancies (Gravidity): Defined as the number of times a woman 
reported being pregnant (continuous measure). For the current analysis, gravidity 
was evaluated as a continuous and a categorical variable. Based on the 
distribution of this variable within the population, categories such as ≤2, 3-5 and 
>5 pregnancies were created. 
Age at First Birth: Defined as age reported for the completion of the first 
pregnancy irrespective of whether it resulted in a live birth, miscarriage, abortion 
or other outcomes. Age at first birth was measured by the primary study as a 
continuous variable. It was analyzed by the current study as a continuous and a 
categorical variable. Based on the distribution of the variable within the 
population, a combination variable was created with categories such as 
“unknown”, “never pregnant”, “<18”, “18-20” and “≥21” years of age at first birth; 
missing values were categorized as “unknown”. 
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Age at First Live-Birth: Defined as the age reported for the first pregnancy that 
resulted in a live-birth (continuous measure).  Similar to age at first birth, this 
variable was also categorized, for the current analysis, as “unknown”, “never 
pregnant”, “<18”, “18-20” and “≥21” years, based on the distribution of this 
variable in the study population; missing values were categorized as “unknown”. 
Birth Control (BC) use: Defined as self-reported use of any birth control by the 
participant. Birth control use was classified as “ever”, “never” or “unknown”. 
2.5 Covariates 
Age: Defined as the reported age (in years) of the participant at the time the 
questionnaire was administered (analyzed as a continuous measure). 
Tobacco use: Classified as “ever” and “never”.  A participant was assigned to the 
“ever” category if she reported smoking >100 cigarettes, bidi, kankat or choor, 
over her lifetime. Otherwise, the subject was categorized as a “never” smoker. 
Years of tobacco product use: Defined as the total years of use of individual 
tobacco product (including filtered and unfiltered cigarettes, bidi, kankat or choor, 
hookat or pipe and hashish); analyzed as a continuous measure. 
Cumulative active smoking: Defined as the sum of the total years of use of each 
tobacco product. This variable was used as a continuous variable for logistic 
regression adjustment and as a categorical variable (with categories: <15 year 
and ≥ 15 years) for the stratified analysis. The categories for the stratified 




Pack-years of smoking: Calculated by multiplying years of use by frequency of 
use divided by 20 for each tobacco product (analyzed as a continuous measure). 
Body Mass Index (BMI): Generated using the weight of women (self-reported for 
the year before the questionnaire was administered) in kilograms divided by their 
height in meters squared. This variable was used as a continuous variable. 
Residential area: Defined as the most current self-reported residential area; 
classified as “Rural” or “Urban”. 
Ethnicity: Determined based on the participant’s report of their ethnicity, 
categorized as Brahmin, Chettri, Rai, Madishe, Limbu, Magar, Tharu or other. 
Due to the similarities between the Madishe and Tharu ethnicities, the present 
analysis combined the Madishe and Tharu ethnicity to form a “Madishe/Tharu” 
group. Rai, Limbu, Magar and others were combined into one group to form the 
“Other” group. 
First degree family history of cancer: Defined on the basis of having at least one 
first degree relative (father, mother, brothers, sisters, sons or daughters) who 
have or had cancer (of any site); classified as “yes” or “no” in the analysis. 
History of medical conditions (such as tuberculosis, asthma, bronchitis, allergic 
eczema, emphysema, pneumonia, silicosis, and asbestosis): Participants self-
reported history of these medical conditions, indicated by “yes” or “no” on the 
questionnaire. The dichotomous variables were used in analyses. 
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Education: Defined as the highest level of education received. Categories such 
as “None”, “Elementary” and “High school” were formed, based on the 
distribution of this variable within the population. The “None” category included 
subjects who reported having no education. “Elementary” included individuals 
who reported having any education upper to 7th standard. The “High school” 
category consisted of individuals who reported their highest level of education as 
8th standard or above. 
Alcohol consumption: Classified as “ever” and “never”. Participants were 
assigned to the “ever” category if they reported consuming any alcoholic 
beverage at least once a week for at least six months during their lifetime.  
Marital status: Defined as the reported marital status at the time of the study and 
categorized as “Married” and “Unmarried/Widowed”. 
Family Monthly Income: The primary study asked participants to indicate their 
monthly family income using categories such as <500, 500-999, 1000-1999, 
2000-4999 and ≥5000 rupees. For the current analysis, these categories were 
further reduced to “≤999”, “1000-1999” and “≥2000”. 
2.6 Data Analysis 
Data management procedures were employed including checking for 
incorrect or implausible values. Simple descriptive statistics on the independent 
variables (means, standard deviations, frequencies and cross-tabs) were used to 
check for extreme values or coding errors. The frequency distributions of each 
variable of interest were checked and analytic variables were generated as 
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needed. Continuous variables were categorized as needed, based on the 
distribution among controls, and the frequency distributions of the newly 
categorized variables were also checked.  
Descriptive characteristics of the cases and controls were compared using 
the student’s t-tests and chi-square tests. Odds ratios (ORs) and 95% confidence 
intervals (CIs) for the association between each exposure and lung cancer were 
estimated using logistic regression. The following parsimonious models were 
performed and are presented here in: 1) unadjusted, 2) age adjusted and 3) age 
and CAS adjusted. Reproductive and hormonal exposures assessed include 
menstrual duration, menopausal status, age at menopause, age at menarche, 
number of pregnancies, age at first birth, age at first live-birth and birth control 
use; unknown categories were retained in the model. Model diagnostics were 
performed for the final models. Additionally, p-trends for all ordinal categorical 
exposure variables in each of these models were calculated using logistic 
regression. 
Based on prior literature, potential confounders were identified a priori, 
including age, smoking history, BMI, residential history, ethnicity, marital status, 
education, family monthly income, first degree family history of cancer, history of 
medical condition (including tuberculosis, asthma and pneumonia), and alcohol 
consumption. After adjusting for CAS, none of the above mentioned potential 
confounders changed the estimated ORs by more than 10%. Thus, the final 
parsimonious model included adjustment for age and CAS.  Additionally, a final 
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model that mutually adjusted for all exposure variables of interest was created 
using logistic regression, and ORs and 95% CIs were estimated.  
Lastly, ORs and 95% CIs for the relationship between each exposure 
variable of interest and lung cancer were calculated by strata of cumulative active 
smoking years. Individual interaction terms (between each exposure of interest 
and CAS) were checked for significance by comparing likelihood ratios of the full 
model (with interaction term) and the reduced model (without interaction term).  
P-trends related to these stratified associations were also calculated as 
described above.  
The SAS statistical package, version 9.3, was used for all statistical 
analyses. All p-values were 2-sided. 
2.7 Human Subjects 
The Institutional Review Board (IRB) committees of the University of Utah, 
University of Maryland and the Nepal Health Research Council approved the 
primary case-control study. As the project described herein is a secondary data 
analysis, the University of Maryland IRB determined that no additional human 









3.1 Medical History and Socio-Demographic Characteristics (Table 1A) 
Compared to controls, cases were slightly older (p-value<0.0001) and less 
educated (p-value<0.0001), and had lower family income (p-value=0.0002). 
Additionally, cases were more likely to be unmarried or widowed (p-
value=0.0002) and to reside in rural areas (p-value=0.02). Cases and controls 
also varied in their ethnic background (p-value<0.0001), whereby, the control 
group had a higher proportion of Brahmins (29.2%) compared to cases (11.6%), 
and more than fifty percent of cases were included in the “other” ethnic groups.  
In terms of lifestyle factors, cases were more likely to have consumed 
tobacco products (p-value<0.0001) and/or alcohol (p-value<0.0001), to have a 
slightly lower body mass index (BMI) (p-value<0.0001). When smoking behaviors 
of the cases and controls were analyzed in more detail, results indicated that 
cases reported greater cumulative active smoking years (p-value<0.0001) and 
pack-years of smoking (p-value<0.0001). Closer examination revealed that the 
difference between cases and controls was not statistically significant for years of 
filtered cigarette use (p-value=0.1). Nevertheless, these groups were significantly 
different with respect to years of use of unfiltered cigarette (p-value<0.0001), bidi 




Cases and controls were similar with regards to family history of cancer 
among first degree relatives (p-value=0.28) and prior diagnosis of asthma (p-
value=0.31). However, cases were more likely to report a prior history of 

















Table 1A: Characteristics of Women Enrolled in the Hospital-Based Lung Cancer Case-
Control Study in Bharatpur, Nepal, 2009-2012 (n= 493) 
 
Cases (n= 267) Controls (n= 226) p-valuea 
  Mean ± SD 
Age (years) 59.2 ±  11.6 53.2 ±  9.6 <0.0001 
BMI (kg/m²) 20.1 ± 3.5 22.6 ± 4.0 <0.0001 
Years of tobacco product use      
 Cigarettes with filter 5.5 ± 12.5 3.8 ± 10.2 0.1 
Cigarettes without filter 24.9 ± 22.5 7.0 ± 13.6 <0.0001 
Bidi 12.3 ± 19.5 2.7 ± 8.9 <0.0001 
Choor/Kankat 4.6 ± 13.0 0.9 ± 5.3 <0.0001 
Hooka/Pipe & Hashish 2.2 ± 10.8 0.5 ± 3.9 0.02 
Cumulative number of active smoking years 49.6 ± 32.5 15.1 ± 23.2 <0.0001 
Pack-years of smoking 24.7 ± 28.2 5.5 ± 11.9 <0.0001 
  N %
b N %b p-valuec 
Ethnicity 
    
<0.0001 
Brahmin 31 11.6 66 29.2  
Chettri 56 21 37 16.4  
Madishe/Tharu 29 10.9 22 9.7  
Other 151 56.6 101 44.7  
Marital status     0.0002 
Married 187 70.0 191 84.5  
Unmarried/Widowed 80 30.0 35 15.5  
Residential area     0.02 
Urban 35 13.1 47 20.8  
Rural 232 86.9 179 79.2  
Education     <0.0001 
None 242 90.6 157 69.5  
Elementary 15 5.6 42 18.6  
High School 10 3.8 27 12.0  
Family Monthly Income (Rupees)     0.0002 
≤ 999 69 25.8 29 12.8  
1000-1999 74 27.7 55 24.3  
≥ 2000 124 46.4 142 62.8  
First Degree Family history of cancer (Yes) 79 29.6 57 25.2 0.28 
History of tuberculosis (Yes) 30 11.2 11 4.9 0.01 
History of asthma (Yes) 23 8.6 14 6.2 0.3 
History of pneumonia (Yes)d 13 4.9 3 1.3 0.04 
Alcohol consumption (Ever) 94 35.2 42 18.6 <0.0001 
Tobacco use (Ever) 234 87.6 97 42.9 <0.0001 
Abbreviations: BMI, body mass index; SD, standard deviation; N, number of participants. 
a P-values generated by t-test. 
b Percentages may not add up to 100 because of rounding. 
c P-values generated by chi-square test. 




3.2 Reproductive and Hormonal Characteristics (Table 1B) 
When reproductive and hormonal characteristics of the study population 
were evaluated as a continuous variable, the cases and controls were similar 
with regards to menstrual duration (p-value=0.09) and age at menopause (p-
value=0.30) among post-menopausal women. Additionally, the reported age at 
menarche of all cases and controls were comparable (p-value=0.27). Among 
those who reported being pregnant, the cases and controls were similar with 
respect to age at first birth (p-value=0.42) and age at first live-birth (p-
value=0.38). Nevertheless, cases were observed (p-value=0.003) to have a 
slightly higher number of pregnancies (mean=5.1; standard-deviation=2.6) 
compared to controls (mean=4.4; standard deviation=2.4). 
When these reproductive and hormonal characteristics were examined as 
a categorical variable, the cases and controls remained similar with regards to 
age at menarche (p-value=0.17) within the entire analytic population, and with 
regards to age at first birth (p-value=0.83) and age at first live-birth (p-value 
=0.87) among the women who reported being pregnant. However, cases and 
controls were significantly different (p-value<0.0001) when the combination 
categories of age at menopause (including pre-menopausal and post-
menopausal women) were considered. Additionally, a greater proportion of 
controls (31.4%) reported that they were still menstruating compared to cases 
(9.4%) (p-value<0.0001). Furthermore, cases were less likely to have used birth 
controls compared to their counterparts (p-value =0.04). Lastly, after 
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categorization, number of pregnancies remained statistically significantly different 
between cases and controls (p-value=0.005). 
 
Table 1B: Reproductive and Hormonal Characteristics of Women Enrolled in the 
Hospital-Based Lung Cancer Case-Control Study, 2009-2012 
 
Cases (n= 267) Controls (n= 226) p-valuea 
  Mean ± SD 
Menstrual Durationb (years) 31.2 ± 5.2  32.2 ± 5.1 0.09 
Age at Menopauseb (years) 46.3 ± 5.0 46.9 ± 4.8 0.3 
Age at Menarche (years) 14.9 ± 1.7 14.7 ± 1.6 0.3 
Number of Pregnancies (gravidity) 5.1 ± 2.6 4.4 ± 2.4 0.003 
Age at First Birthc (years) 20.0 ± 3.5 19.8 ± 3.3 0.42 
Age at First Live Birthc (years) 20.1 ± 3.6 19.8 ± 3.4 0.38 
  N %d N %d p-valuea 
Still Menstruating (Yes) 25 9.4 71 31.4 <0.0001 
Age at Menopause (years) 
    
<0.0001 
Pre-menopausal 25 9.4 71 31.4 
 <45 61 22.9 39 17.3 
 45-49 98 36.7 55 24.3 
 ≥50 71 26.6 52 23.0 
 Age at Menarche (years) 
    
0.17 
<14 46 17.2 50 22.1 
 14 58 21.7 62 27.4 
 ≥15 134 50.2 101 44.7 
 Number of Pregnancies (Gravidity) 
    
0.005 
≤2 40 15.0 43 19.0 
 3-5     116 43.5 121 53.5 
 >5 111 41.6 62 27.4 
 Age at First Birth (years) 
    
0.8 
Never Pregnant 15 5.6 10 4.4 
 <18 50 18.7 47 20.8 
 18-20 100 37.5 80 35.4 
 ≥21 77 28.8 69 30.5 
 Age at First Live-Birth (years) 
    
0.9 
Never Pregnant 15 5.6 10 4.4 
 <18 50 18.7 47 20.8 
 18-20 98 36.7 80 35.4 
 ≥21 79 29.6 69 30.5 
 Birth Control Use (Ever) 29 10.9 39 17.3 0.04 
            
Abbreviations: SD, standard deviation; N, number of participants. 
   a P-values generated by t-test or chi-square test; unknown category or missings excluded. 
b Only among post-menopausal women. 
     c Only among women who reported being pregnant. 
    d Percentages may not add up to 100 because of rounding and due to unknown categories (not shown). 
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3.3 Multivariable Logistic Regression (Table 2) 
Unadjusted multivariable logistic regression indicated an increased odds 
of lung cancer among women with greater than five pregnancies when compared 
to those with three to five pregnancies (OR=1.87; 95%CI=1.25, 2.79). 
Additionally, women who reported to have ever used birth control had a 
decreased odds of lung cancer (OR=0.58; 95%CI=0.35, 0.97), in this preliminary 
examination of the data. No statistically significant associations between 
menstrual duration (among post-menopausal women), menopausal status, age 
at menopause (among post-menopausal women), age at menarche, age at first 
birth, and age at first live-birth were observed within this unadjusted model. 
After adjusting for age, the relationship between number of pregnancies 
and lung cancer, as well as that between birth control use and lung cancer, no 
longer remained statistically significant (OR >5 vs. 3-5=1.43; 95%CI >5 vs. 3-5=0.94, 
2.18 and OR ever vs. never=0.86; 95%CI ever vs. never =0.50, 1.49, respectively). 
However, this age-adjusted model, among post-menopausal women, suggested 
that women with longer menstrual duration had decreased odds of lung cancer 
compared to those with a shorter menstrual duration (OR=0.94; 95%CI=0.90, 
0.99). The relationship between other reproductive and hormonal factors, 
examined in this analysis, and lung cancer remained statistically non-significant 




Final parsimonious models adjusted for age and CAS are also 
summarized in Table 2.  Among post-menopausal women, women with a 
younger age at menopause (<45 years and 45-49 years) had an increased odds 
of lung cancer compared to women who were ≥ 50 years at menopause 
(OR=2.14; 95%CI=1.09, 4.17 and OR=1.93; 95%CI=1.07, 3.51, respectively), 
after adjusting for age and cumulative active smoking (CAS) years. The p-trend 
for age at menopause, with respect to lung cancer, was also statistically 
significant (p-trend = 0.02) for the age and CAS adjusted model suggesting a 
dose-response relationship. Furthermore, among post-menopausal women, 
women with longer menstrual duration continued to have a decreased odds of 
lung cancer compared to those with a shorter menstrual duration (OR=0.93; 
95%CI=0.88, 0.98), for the age and cumulative smoking adjusted model.  Lastly, 
women who reported to be still menstruating had a decreased odds of lung 
cancer compared to those who had stopped menstruating (OR=0.41; 
95%CI=0.20, 0.85). The remaining reproductive and hormonal factors (which 
were not associated with lung cancer in the previous models) were not 







Table 2: Multivariable Odds Ratios and 95% Confidence Intervals for the Relationship 
between Reproductive and Hormonal Factors and Lung Cancer in the Hospital-
Based Lung Cancer Case-Control Study, 2009-2012 
 
Cases Controls Unadjusted Age-Adjusted 
Age & CAS 
Adjusteda 
  N N OR (95% CI) OR (95% CI) OR (95% CI) 
Menstrual Durationb 
(years) 213 142 0.97 (0.93, 1.01) 0.94 (0.90, 0.99) 0.93 (0.88, 0.98) 
Still Menstruating 
        Yes 25 71 0.21 (0.12, 0.34) 0.35 (0.18, 0.65) 0.41 (0.20, 0.85) 
No 196 114 1 (referent) 1 (referent) 1 (referent) 
Age at Menopauseb 
(years) 
        <45 61 39 1.15 (0.67, 1.96) 1.70 (0.95, 3.04) 2.14 (1.09, 4.17) 
45-49 98 55 1.31 (0.80, 2.12) 1.54 (0.93, 2.55) 1.93 (1.07, 3.51) 
≥50 71 52 1 (referent) 1 (referent) 1 (referent) 
p-trenda 
  
0.58 0.06 0.02 
Age at Menarche 
(years) 
        <14 46 50 0.69 (0.43, 1.12) 0.83 (0.50, 1.36) 0.93 (0.53, 1.62) 
14 58 62 0.71 (0.45, 1.10) 0.74 (0.47, 1.17) 0.88 (0.52,1.49) 
≥15 134 101 1 (referent) 1 (referent) 1 (referent) 
p-trenda 
  
0.08 0.32 0.77 
Number of Pregnancies 
(Gravidity) 
        ≤2 40 43 0.97 (0.59, 1.60) 1.00 (0.59, 1.68) 0.87 (0.48, 1.57) 
3-5     116 121 1 (referent) 1 (referent) 1 (referent) 
>5 111 62 1.87 (1.25, 2.79) 1.43 (0.94, 2.18) 1.27 (0.78, 2.08) 
p-trenda 
  
0.004 0.13 0.21 
Age at First Birth (years) 
        Never Pregnant 15 10 1.2 (0.51, 2.81) 1.37 (0.56, 3.3) 1.06 (0.38, 2.97) 
<18 50 47 0.85 (0.52, 1.40) 0.88(0.53, 1.47) 0.79 (0.44, 1.42) 
18-20 100 80 1 (referent) 1 (referent) 1 (referent) 
≥21 77 69 0.89 (0.58, 1.38) 0.89 (0.56, 1.40) 1.74 (0.44, 1.25) 
p-trenda 
  
0.93 0.96 0.72 
Age at First Live-Birth 
(years) 
        Never Pregnant 15 10 1.22 (0.52, 2.87) 1.39 (0.57, 3.39) 1.07 (0.38, 3.00) 
<18 50 47 0.87 (0.53, 1.43) 0.90 (0.54, 1.50) 0.80 (0.44, 1.44) 
18-20 98 80 1 (referent) 1 (referent) 1 (referent) 
≥21 79 69 0.94 (0.60, 1.45) 0.93 (0.59, 1.46) 0.76 (0.45, 1.28) 
p-trenda 
  
0.83 0.96 0.76 
Birth Control Use 
        Ever 29 39 0.58 (0.35, 0.97) 0.86 (0.50, 1.49) 0.79 (0.42, 1.50) 
Never 227 177 1 (referent) 1 (referent) 1 (referent) 
Abbreviations: CAS, Cumulative Active Smoking; N, number of participants; OR, odds ratio; CI, 
confidence interval. 
  a Estimates were adjusted for age and cumulative active smoking years; one subject with missing cumulative active 
smoking history was excluded. 
b Premenopausal women not  included. 




3.4 Model Mutually Adjusted for Reproductive & Hormonal Factors (Table 3) 
After  simultaneously adjusting for reproductive and hormonal factors  
(including age at menarche, age at menopause, number of pregnancies or 
gravidity, age at first live-birth, and birth control use) along with adjustment for 
age and cumulative active smoking history, no significant relationships with lung 
cancer were observed at α = 0.05. However, the increased odds of lung cancer 
among women with younger age at menopause (<45 years and 45-49 years) was 
still observed (OR=1.7; 95%CI=0.90, 3.4 and OR=1.7; 95%CI=0.90, 3.2, 














Table 3: Mutually Adjusted Odds Ratios and 95% Confidence Intervals of Reproductive and Hormonal Factors in Relation to Lung 
Cancer in the Hospital-Based Lung Cancer Case-Control Study 
 
Age at Menarche 
(years) 








  <14 14 ≥15 
Pre-
Menopausal <45 45-49 ≥50 ≤2 3-5 >5 
Never 
Pregnant <18 18-20 ≥21 Ever Never 
Cases 46 58 134 25 61 98 71 40 116 111 15 50 98 79 29 227 
Controls 50 62 101 71 39 55 52 43 121 62 10 47 80 69 39 177 





























Abbreviations: OR, odds ratio; CI, confidence interval. 
         a Estimates were adjusted for age and cumulative active smoking years, and exposures listed in the above table as applicable; one subject with missing cumulative active smoking 
history was excluded. 









3.5 Effect Modification by Smoking Status (Table 4) 
After stratifying by cumulative active smoking (CAS) years, younger age at 
menopause (specifically <45 years) remained significantly associated with a 
higher odds of lung cancer among post-menopausal women with a cumulative 
active smoking history of at least 15 years (OR=2.27; 95%CI=1.02, 5.04). 
Similarly, among post-menopausal women, the inverse relationship between 
menstrual duration and lung cancer only remained significant among those who 
reported smoking for greater than or equal to 15 cumulative years over their 
lifetime. On the other hand, women who reported to be still menstruating had 
decreased odds of lung cancer among both strata (<15 and ≥15 years) of CAS. 
Lastly, the relationships between all other reproductive and hormonal factors 
examined (i.e. age at menarche, number of pregnancies, age at first birth, age at 
first live-birth and birth control use) and lung cancer were not significant within 
both strata of cumulative active smoking. Interactions terms were statistically 
significant for the number of pregnancies, age at first birth and age at first live-








Table 4:  Multivariable Odds Ratios and 95% Confidence Intervals of the Relationship 
between Reproductive and Hormonal and Lung Cancer by Smoking Status 
 
< 15 Cumulative Active Smoking 
Years 
≥ 15 Cumulative Active Smoking 
Years 
 
Cases Controls OR (95% CI)a Cases Controls OR (95% CI)a 
  n n n n 
Menstrual Durationb (years) 18 81 0.95 (0.84, 1.07) 194 61 0.92 (0.87, 0.98) 
Still Menstruating 
        Yes 17 60 0.30 (0.10, 0.92) 8 11 0.29 (0.09, 0.88) 
No 17 61 1 (referent) 179 53 1 (referent) 
Age at Menopauseb (years) 
        
<45 6 25 
2.46 (0.49, 
12.24) 55 14 2.27 (1.02, 5.04) 
45-49 10 33 
3.33 (0.76, 
14.60) 88 22 1.81 (0.92, 3.57) 






Age at Menarche (years) 
        <14 11 32 1.68 (0.65, 4.30) 35 18 0.71 (0.35, 1.44) 
14 10 45 1.01 (0.39, 2.61) 48 17 0.89 (0.44, 1.78) 






Number of Pregnancies 
(Gravidity) 
        ≤2 9 27 1.20 (0.46, 3.13) 31 16 0.62 (0.29, 1.32) 
3-5     19 85 1 (referent) 96 36 1 (referent) 






Age at First Birth (years) 
        
Never Pregnant 4 5 
3.78 (0.81, 
17.62) 11 5 0.44 (0.13, 1.48) 
<18 9 27 1.90 (0.67, 5.37) 41 20 0.51 (0.25, 1.08) 
18-20 11 58 1 (referent) 89 22 1 (referent) 






Age at First Live-Birth 
(years) 
        
Never Pregnant 4 5 
3.78 (0.81, 
17.62) 11 5 0.45 (0.13, 1.51) 
<18 9 27 1.90 (0.67, 5.37) 41 20 0.52(0.25, 1.10) 
18-20 11 58 1 (referent) 87 22 1 (referent) 






Birth Control Use 
        Ever 9 28 1.07 (0.43, 2.65) 19 11 0.63 (0.26, 1.49) 
Never 27 115 1 (referent) 200 62 1 (referent) 
Abbreviations: OR, odds ratio; CI, confidence interval. 
      a Estimates were adjusted for age and cumulative active smoking years, and exposures listed in the above table as 
applicable; one subject with missing cumulative active smoking history was excluded. 






4.1 Current Findings 
Findings from this first analysis of reproductive and hormonal factors in 
relation to lung cancer among Nepali women suggest a potential role for 
menopausal factors.  More specifically, among post-menopausal women, 
younger age at menopause was associated with an increased odds of lung 
cancer, after adjusting for age and cumulative active smoking. Additionally, 
longer menstrual duration was inversely associated with odds of lung cancer, 
among post-menopausal women. Premenopausal women (or still menstruating 
women) had a decreased odds of lung cancer compared to postmenopausal 
women (or women who had stopped menstruating). Finally, the relationships 
between age at menarche, number of pregnancies, age at first birth, age at first 
live-birth and birth control use, and lung cancer were not statistically significant 
among the analytic population, after controlling for age and cumulative active 
smoking history. 
4.2 Prior Studies 
Although some studies have reported null associations between age at 
menopause and lung cancer15, 18, 21, 22, 29, others have reported an inverse 
association between these two variables17, 19, 23, 30. Prior to conducting this 
analysis, it was hypothesized that women with an older age at menopause will 
have an increased odds of lung cancer. However, results showed that women 
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with a younger age at menopause had an increased odds of lung cancer, which 
is consistent with the majority of prospective cohort studies that have examined 
this relationship17, 19, 23. Liu et al. hypothesized that this inverse association may 
be due to the fact that women with younger age at menopause may be using 
exogenous hormones for a longer period (compared to those with older age at 
menopause) 28.  However, this may not be an appropriate explanation for the 
current study population, as only two cases and one control reported using 
hormones for the symptoms of menopause.  
Parker et al. 36 and Koushik et al. 21 have reported increase lung cancer 
risk among women with bilateral oophorectomies. Similarly Brinton et al. 17 
observed that among women who had bilateral oophorectomies, the risk of lung 
cancer was significantly higher with younger age at menopause. However, the 
same relationship between younger age at menopause and lung cancer was not 
observed among those who had hysterectomies with ovarian conservation17. 
Thus, there is a possibility that the untimely termination of ovarian function might 
be involved in the observed inverse association between age at menopause and 
lung cancer17. The current study did not have information on the type of 
menopause, and therefore, this potential explanation could not be explored. 
However, it is worth noting that the number of Nepali women who may have had 
bilateral oophorectomies or other surgically assisted menopause is expected to 
be relatively low. In conclusion, the precise phenomenon behind the observed 
inverse association between age at menopause and lung cancer within the 
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analytic population cannot be asserted with total confidence and further studies 
are needed to better elucidate this relationship. 
With respect to the significant associations that were only observed 
among women who smoked for at least 15 cumulative active smoking years, 
when data were stratified by smoking status, these results should be interpreted 
with caution due to the small cell numbers among the strata. This was due the 
fact that very few cases within the analytic population had reported smoking for 
<15 CAS years. Nevertheless, Brinton et al. 17, also observed differences in 
associations when stratifying by smoking status, whereby the statistically 
significant inverse associations between age at menopause and lung cancer only 
remained significant among former and/or current smokers (but not among never 
smokers). One suggested explanation for these findings is that the stronger 
binding of estrogen to estrogen receptors may inhibit the carcinogenic effects of 
polycyclic aromatic hydrocarbons that bind to these receptors, among smokers17, 
37. Thus, women with younger age at menopause (who have lower levels of 
endogenous estrogens) may be more susceptible to the carcinogenic effects of 
tobacco smoke. Further research is needed to understand the underlying 
mechanisms of this relationship. 
The current analysis also observed that women who were still 
menstruating had decreased odds of lung cancer compared to those who had 
stopped. It is possible that the observed association may be due to selection bias 
as the controls included a higher percentage of still menstruating women 
compared to cases. It is possible that the menopausal status of participants may 
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have been affected by case status as self-reported data was collected after 
diagnosis of lung cancer. Additionally, cases were slightly older compared to the 
controls in the analytic population (Table 1), which may have contributed to the 
observed association even after adjusting for age, due to residual confounding. 
Moreover, the temporal trend between these two variables is a little unclear due 
to the retrospective nature of this study. Thus, future studies, particularly among 
Nepali or similar populations, should execute a more rigorous analysis of this 
relationship. 
To date, the majority of prior studies have not observed significant 
associations between age at menarche and lung cancer15-16, 18-19, 21-23, 25, 29-30. 
Our findings are consistent with the observations made in various case-control 
and prospective studies conducted among Chinese15-16, 22-23, 30, Canadian, 21, 25 
American18-19, and German29 women populations. Inverse associations between 
age at menarche and lung cancer has been noted by Brinton et al.17and Brenner 
et al.30 among the participants of the NIH-AARP Diet and Health study cohort and 
a population-based frequency matched Chinese women case-control study, 
respectively. Brinton et al. reported that after stratifying by smoking status, the 
inverse association between age at menarche and lung cancer was only 
significant among never smokers17. Due to the limited distribution of the smoking 
variable in the current study population (never smokers=12.4% case and 42.9% 
controls), we were unable to examine associations among never smokers.  
Additionally, Brinton and colleagues reported a reduced risk of 
adenocarcinoma and undifferentiated/large cell lung cancer with later age at 
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menarche, after stratifying by histological subtypes17. This finding may be an 
indication that difference in lung cancer histology among the participants of the 
various studies may be a key factor leading to the inconsistences noted in 
findings across studies. The null findings observed in our study may be specific 
to the histologic distribution of lung cancer among the Nepali women population. 
However, we were unable to conduct analyses by histologic type as this 
information was not available. 
Number of pregnancies (gravidity) and number of births (parity) are closely 
related variables that may be associated with lung cancer among women. Only 
one study has examined the relationship between number of pregnancies or 
gravidity and lung cancer21. The investigators of this previous analysis, which was 
a population-based case-control study conducted among 422 women with lung 
cancer and 577 population-based controls from Montreal, Canada, reported no 
significant association between gravidity and lung cancer21. On the other hand 
several studies that have examined the relationship between number of births or 
parity and lung cancer have reported an inverse association between these 
variables15-16, 18, 20, 22-23. Earlier studies conducted by Kabat et al. 25 and Elliott et 
al. 27 among British and Canadian women, respectively, found a positive 
association between parity and lung cancer. However, two recent large 
prospective cohort studies, by Brinton et al. 17 and Baik et al., 19 have reported 
null associations between parity and lung cancer (among the NIH-AARP Diet and 
Health study cohort and the Nurses’ Health Study cohort, respectively). Among 
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the Nepali female population investigated, the current study observed results that 
were similar to these cohort findings. 
With respect to age at first birth, our results were consistent with several 
studies that have reported no association between age at first birth and lung 
cancer15-16, 18, 20-21, 23, 30.  However, two previous studies, Brinton et al. 17 and 
Kabat et al. 25, have reported an inverse association between age at first birth 
and lung cancer among the NIH-AARP Diet and Health study cohort and the 
Canadian National Breast Screening Study (NBSS) cohort, respectively. The 
inverse association among the NIH-AARP cohort only remained significant 
among current smokers after stratification by smoking status17, whereas this 
association was significant among both the “never” and “ever” smokers in the 
study by Kabat et al. 25. More importantly, when stratified by lung cancer 
histology, Kabat and coworkers found no significant association between age at 
first birth and adenocarcinoma, whereas those with other lung cancer cell types 
(other than adenocarcinoma) continued to demonstrate an inverse association 
with age at first birth25. This difference in the relationship between age at first 
birth and lung cancer based on histology may explain the varied findings reported 
by investigators using different study designs and studying different populations. 
To our knowledge, no prior study has examined the association between 
age at live-birth and lung cancer. However, the results of the current analysis are 
similar to the findings reported in the above mentioned studies which examined 
the relationship between age at first birth and lung cancer. 
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 Lastly, no significant associations between oral contraceptive (OC) use 
(never and ever use) and lung cancer have been reported by the majority of 
studies using both case-control and cohort study designs among different 
populations of women16-19, 22-23, 25, 27. Only one study, a population-based case-
control study conducted in Germany, has reported a decreased odds of lung 
cancer among ever OC users compared to never users29. This association was 
reported to be significant only among smokers, after stratification by smoking 
status29. After stratifying by histological subtypes, the investigators reported that 
this association remained significant among those with small cell lung cancer and 
squamous cell carcinoma, but not among those with adenocarcinoma29. Our 
findings showed reduced odds of lung cancer among ever birth control user 
compared to never user. However, it may not be ideal to compare these findings 
with the previous study, as definitions of birth control type may vary by study. 
Thus, no major conclusions may be drawn from the findings on birth control use, 
as detailed information on the form of birth control use was not available. 
4.3 Strengths and Limitations 
Generally, case-control studies are more susceptive to selection bias (the 
exposure status of the subjects may influence the differential selection of cases 
and controls) and recall bias (controls may have recalled exposures differently 
than the lung cancer patients). However, this is unlikely with respect to the 
current analysis, where factors such as number of pregnancies and menopausal 
age constitute the independent variables. Moreover, although temporal ambiguity 
is normally implicated in retrospective study designs, it is not suspected to be a 
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hindrance in the current research due to the low likelihood that a participant 
experienced reproductive or hormonal events (such as menarche and 
pregnancy) due to lung cancer. However, the temporal trend with respect to 
menopausal variables (such as menopausal status and age at menopause) is 
unclear in this retrospective analysis. Additionally, the definition of menopausal 
status was based on self-reported menstrual status, and thus, exposure 
misclassification is also a potential limitation of this analysis. 
Another potential limitation of this study is that the controls in this analysis 
included subjects being screened at the cancer hospital, and thus, it is possible 
that some of these controls might have cancer of some other type (participants’ 
prior history of cancer were limited to self-report and not confirmed). This might 
have biased the odds towards the null, given that some of these cancers (e.g. 
breast cancer) may share the same risk factors under study.  
The current analysis was unable to examine associations among never 
smokers, due to the distribution of the smoking variable in the study population. 
Additionally, these associations were also not analyzed by strata of menopausal 
status, due to the limited number of premenopausal women in the study. 
Moreover, data on the type of menopause (natural, surgical, or due to radiation 
or chemotherapy) would have been helpful in discerning if the associations 
between age at menopause and lung cancer were specific to any particular type 
of menopause. Finally, information on lung cancer histology and specific types of 
birth control use may have been more informative in clarifying these associations 
further within this population. 
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Despite these limitations, this is the first study to examine the relationship 
between reproductive and hormonal factors and lung cancer among Nepali 
women, which is an understudied population. Additionally, the current analysis is 
one of the few studies to access the effects of gravidity (number of pregnancies) 
and age at first live-birth in relation to lung cancer. Moreover, due to the long 
latency period of lung cancer, the case-control study design of our study made it 
time and financially efficient. Lastly, the use of trained nurses and standardized 
questionnaire, and detailed data collection through in-person interviews were 
some additional strengths of this study. In addition to contributing to the 
epidemiological body of evidence surrounding potential associations between 
reproductive and hormonal factors and lung cancer, this study contributes much 
needed information on the distribution of these risk factors among Nepali women. 
4.4 Recommendations for Future Studies 
Based on prior studies and the current findings, future research should 
focus on understanding the relationships between these risk factors and the 
specific histological types of lung cancer. Additionally, considering the type of 
menopause (i.e. natural, surgical, or due to radiation or chemotherapy) may be 
important for clarifying the relationship between these factors and lung cancer (or 
particular histological subtypes of lung cancer). Large sample sizes should be 
utilized wherever possible to support adequate cell numbers among strata 
formed by effect modifiers (e.g. smoking status). In summary, more studies are 
needed to understand the relationship between reproductive and hormonal factor 
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and lung cancer with respect to type of menopause and lung cancer histology 
overall and specifically among the understudied Nepali population. 
4.5 Conclusion 
To our knowledge, this was the first study to examine the relationship 
between reproductive and hormonal factors and lung cancer among Nepali 
women. The current analysis, found that cases and controls were significantly 
different with respect to age, ethnicity, education, family monthly income, 
smoking behaviors, menstrual status, age at menopause, number of pregnancies 
and birth control use. This study also observed that women who were still 
menstruating (premenopausal) had a reduced odds of lung cancer compared to 
those who had stopped (postmenopausal). Our results support increased odds of 
lung cancer with younger age at menopause, after adjustment for age and 
cumulative active smoking years. After stratifying by cumulative active smoking 
years, younger age at menopause remained significantly associated with higher 
odds of lung cancer only among those with a cumulative active smoking history 
of at least 15 years. These results are consistence with a majority of the recent 
large prospective cohort studies. Future studies should pay close attention to the 
histological types of lung cancer, type of menopause and type of oral 
contraceptives used by the study participants. Findings from this analysis support 
a potential role of menopausal factors in relation to lung cancer among Nepali 
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APPENDIX B: Supplementary Table 1: Age at Menarche 
 
Authors Study Design Population Key Findings Effect Modifiers 
Brenner et al.  
(2003) 30 
Case-Control 
Variable Type: Categorical;  
1) <15, 15-16 and ≥17years 
Confounder Adjustment:  
Age and prefectures 
(Pingliang and Qingyang). 
109 incident female lung 
cancer cases and 435 
population-based frequency 
matched (on gender and age) 
controls recruited from 
hospitals in two rural 
prefectures (Pingliang and 
Qingyang) in Eastern Gansu 
Province, China, between 
January 1994 and April 1998. 
There is an inverse 
association 
between age at 
menarche and lung 
cancer (P for trend 
=0.015). 
Not analyzed 
Kreuzer et al. 
(2003) 29 
Case-Control 
Variable Type: Categorical;  
1) <13, 13-14 and ≥15 years       
Confounder Adjustment:  
Age, region, pack years of 
smoking, smoking status, 
and education. 
811 women with lung cancer 
and 912 population controls 
enrolled between 1990 and 
1996 in Germany. 
There was no 
significant 
association 
between age at 
menarche and lung 
cancer. 
Smoking status: There was no significant association 
between age at menarche and lung cancer after 
stratifying by smoking status (non-smokers and 
smokers). 
Histological subtypes: There was no significant 
association between age at menarche and lung 
cancer after stratifying by histology (adenocarcinoma, 
small cell carcinoma and squamous carcinoma). 
Kabat et al. 
(2007) 25 
Cohort 
Variable Type: Categorical;  
1) <12, 12, 13, 14 and 
>14years 
Confounder Adjustment:  
Body mass index, education, 
smoking status, pack-years 
of smoking, study center and 
randomization group 
(intervention versus control), 
other exposure variables. 
89,835 Canadian women aged 
40–59 years recruitment in the 
Canadian National Breast 
Screening Study (NBSS), a 
randomized controlled trial of 
screening for breast cancer, 
between 1980 and 1985. 
The association 
between age at 
menarche and lung 
cancer was not 
statistically 
significant. 
Smoking status: There was no significant association 
between age at menarche and lung cancer after 
stratifying by smoking status (never and ever). 
Histological subtypes: There was no significant 
association between age at menarche and lung 
cancer after stratifying by histology (Adenocarcinoma 
and other cell types). 
Age: There was no significant association between 
age at menarche and lung cancer after stratifying by 
age (40-49 and 50-59 years). 
40 
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Authors Study Design Population Key Findings Effect Modifiers 
Weiss et al. 
(2008) 23 
Cohort                         
Variable Type: Categorical; 
1)<15, 15-16, and ≥17 years 
Confounder Adjustment: 
Passive smoking 
71,314 non-smoking Chinese 
women aged 40-70 with no 
history of cancer at baseline 
from the prospective Shanghai 
Women’s Health Study 
conducted between 1996 and 
2000. 
There was no 
significant 
association 
between age at 
menarche and lung 
cancer. 
Histological subtypes: There was no significant 
association between age at menarche and lung 
cancer among women with adenocarcinoma; this 
relationship was not examined among women with 
other histologic types of lung cancer.                  
Passive smoking: The association between age at 
menarche and lung cancer is not significant among 
women with or without passive smoking exposure. 
Koushik et al. 
(2009) 21 
Case-Control             
Variable Type: Categorical;  
1) <13, 13, 14, and ≥15years 
Confounder Adjustment:  
Age, respondent status, 
ethnicity, education, family 
income, and smoking status. 
422 women with lung cancer 
and 577 population-based 
controls from Montreal, 
Canada recruited between 
January 1996 and December 
1997. 
There was no 
significant 
association 
between age at 
menarche and lung 
cancer. 
Histological subtypes: There was no significant 
association between age at menarche and 
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Authors Study Design Population Key Findings Effect Modifiers 
Seow et al. 
(2009) 22 
Cohort 
Variable Type: Categorical; 
1)  <15 and ≥15 years 
Confounder Adjustment:   
Age, year of interview (1993-
1995, 1996-1998), dialect 
group (Cantonese, Hokkien), 
educational level, body mass 
index (BMI), total vegetable 
intake, total fruit/juice intake, 
β-cryptoxanthin, total 
isothiocyanates, and duration 
of smoking (years), 
cigarettes per day, and 
number of years since 
quitting among current or 
former smokers.          
35,298 women aged 45 to 78 
years recruited into the 
Singapore Chinese Health 
Study between April 1993 and 
December 1998. 
There was no 
significant 
association 
between age at 
menarche and lung 
cancer. 
Smoking status: There was no significant association 
between age at menarche and lung cancer, when 
stratified by smoking status.  
Histological subtypes: There was no significant 
association between age at menarche and lung 
cancer, when stratified by histology. 
Baik et al. 
(2010) 19 
Cohort 
Variable Type: Categorical;  
1) <11, 12, 13, 14 and 
≥15years 
Confounder Adjustment: 
Smoking, fruit/vegetable in- 
take, BMI, environmental 
smoking exposure, and other 
exposure variables. 
107,171 postmenopausal 
women aged 30-55 years 
enrolled in the Nurse's Health 
Study, collected between 1984 
and 2006. 
There was no 
significant 
association 
between age at 
menarche and lung 
cancer. 
Smoking status: There was not significant association 
between age at menarche and lung cancer in the 
various strata based on smoking status.  
Histological subtypes: There was not significant 
association between lung cancer and age a 
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Brinton et al. 
(2011) 17 
Cohort 
Variable Type: Categorical;  
1) <11, 11-12, 13-14 and ≥15 
years 
Confounder Adjustment:   
Age, race/ethnicity, 
education, BMI, emphysema, 
smoking status and dose, 
age at menopause and type 
of menopause.          
185,017 women between the 
ages of 50 and71 years were 
recruited into the NIH-AARP 
(American Association of 
Retired Persons) Diet and 
Health Study during 1995 and 
1996. 
Younger age at 
menarche is 
associated with an 
increased risk for 
lung cancer (P for 
trend = 0.01). 
Smoking status: The inverse association between 
age at menarche and lung cancer was only significant 
among never smokers (P for trend=- 0.03). 
Histological subtypes: There was a reduced risk of 
adenocarcinoma and undifferentiated/large cell was 
observed with later age at menarche (P for trend = 
<0.01 and 0.02, respectively). 
Meinhold et 
al. (2011) 18 
Case-Control 
Variable Type: Categorical;  
1) <12, 12-13, 14-15 and 
≥16years 
Confounder Adjustment:  
Age, education, smoking, 
number of smoking adults in 
household and current 
household income. 
430 women diagnosed with 
non-small cell lung cancer, 316 
hospital controls and 295 
population controls recruited in 
the multi-center Maryland Lung 
Cancer Study between 1998 
and 2008. 
There was no 
significant 
association 
between age at 
menarche and non-
small cell lung 




Smoking status: The association between age at 
menarche and non-small cell lung cancer was not 
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Authors Study Design Population Key Findings Effect Modifiers 
Lim et al. 
(2012) 16 
Case-Control 
Variable Type: Categorical; 
1) ≤12, 13-15 and  ≥16years 
Confounder Adjustment:  
Age, fruit and vegetable 
consumption, country of 
origin, dwelling type, years of 
education, history of cancer 
in first-degree relatives, 
smoking status , secondhand 
smoke exposure at home, 
and  study set. 
702 Chinese female lung 
cancer cases and 1,578 
hospital controls from 2 
hospital-based 
case-control studies, which 
recruited from the 5 major 
public-sector hospitals in 
Singapore during 1996–1998 
and 2005–2008. 
There was no 
significant 
association 
between age at 
menarche and lung 
cancer. 
Smoking status: There was no significant association 
between age at menarche and lung cancer by 
smoking status (never and ever smokers).            
Gallagher et 
al. (2013) 15 
Cohort 
Variable Type: Categorical;  
1) ≤13, 14, 15, 16 and ≥17 
years 
Confounder Adjustment:  
Age and smoking.  
267,400 female textile workers 
in Shanghai, China, enrolled 
between 1989 and 1991 and 
followed until 2000 for 
incidence of lung cancer. 
There was no 
significant 
association 
between age at 
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Authors Study Design Population Key Findings Effect Modifiers 
Brenner et al. 
(2003) 30 
Case-Control             
Variable Type: Categorical;  
1) Natural menopause: <45, 
45-49 and ≥50 years            
Confounder Adjustment:  
Age and prefectures 
(Pingliang and Qingyang). 
109 incident female lung 
cancer cases and 435 
population-based frequency 
matched (on gender and age) 
controls recruited from 
hospitals in two rural 
prefectures (Pingliang and 
Qingyang) in Eastern Gansu 
Province, China, between 
January 1994 and April 1998. 
There is an inverse 
association 
between age at 
menopause and 
lung cancer (P for 
trend =0.074). 
Not analyzed 
Kreuzer et al. 
(2003) 29 
Case-Control             
Variable Type: Categorical;  
1) ≤49, 50-51 and ≥53 years       
Confounder Adjustment:  
Age, region, pack years of 
smoking, smoking status, 
and education. 
811 women with lung cancer 
and 912 population controls 
enrolled between 1990 and 
1996 in Germany. 
There was no 
significant 
association 
between age at 
menopause and 
lung cancer. 
Smoking status: There was no significant association 
between age at menopause and lung cancer after 
stratifying by smoking status (non-smokers and 
smokers). 
Histological subtypes: There was no significant 
association between age at menopause and lung 
cancer after stratifying by histology (adenocarcinoma, 
small cell carcinoma and squamous carcinoma). 
Weiss et al. 
(2008) 23 
Cohort                         
Variable Type: Categorical; 
1)<46, 46-48, 49-50 and ≥51 
years    
Confounder Adjustment: 
Passive smoking 
71,314 non-smoking Chinese 
women aged 40-70 with no 
history of cancer at baseline 
from the prospective Shanghai 
Women’s Health Study 
conducted between 1996 and 
2000. 
Age at menopause 
was inversely 
associated with 
lung cancer risk (P 
for trend = 0.03). 
Histological subtypes: Age at menopause was 
inversely associated with adenocarcinoma; this 
relationship was not examined among women with 
other histologic types of lung cancer.  
Passive smoking: The association between age at 
menopause and lung cancer is not significant among 
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Authors Study Design Population Key Findings Effect Modifiers 
Koushik et al. 
(2009) 21 
Case-Control             
Variable Type: Categorical;  
1) <45, 45-<51 and ≥51years            
Confounder Adjustment:  
Age, respondent status, 
ethnicity, education, family 
income, and smoking status. 
422 women with lung cancer 
and 577 population-based 
controls from Montreal, 
Canada recruited between 
January 1996 and December 
1997. 
There was no 
significant 
association 
between age at 
menopause and 
lung cancer. 
Histological subtypes: There was no significant 
association between age at menopause and 
adenocarcinoma; other histological subtypes were 
not analyzed. 
Types of Menopause: There was no significant 
association between age at natural or non-natural 
menopause and lung cancer (or adenocarcinoma). 
Seow et al. 
(2009) 22 
Cohort                             
Variable Type: Categorical; 
1)  <50  and ≥50 years                                 
Confounder Adjustment:   
Age, year of interview (1993-
1995, 1996-1998), dialect 
group (Cantonese, Hokkien), 
educational level, body mass 
index (BMI), total vegetable 
intake, total fruit/juice intake, 
β-cryptoxanthin, total 
isothiocyanates, and duration 
of smoking (years), 
cigarettes per day, and 
number of years since 
quitting among current or 
former smokers.          
35,298 women aged 45 to 78 
years recruited into the 
Singapore Chinese Health 
Study between April 1993 and 
December 1998. 
There was no 
significant 
association 
between age at 
menopause and 
lung cancer. 
Smoking status: There was no significant association 
between age at menopause and lung cancer, when 
stratified by smoking status.  
Histological subtypes: There was no significant 
association between age at menopause and lung 
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Baik et al. 
(2010) 19 
Cohort                         
Variable Type: Categorical;  
1) <44, 44-47, 48-49, 50-51 
and ≥52 years 
Confounder Adjustment:  
Smoking, fruit/vegetable in- 
take, BMI, environmental 
smoking exposure, and other 
exposure variables. 
107,171 postmenopausal 
women aged 30-55 years 
enrolled in the Nurse's Health 
Study, collected between 1984 
and 2006. 
Age at menopause 
was inversely 
associated with 
lung cancer risk (P 
for trend =0.0004). 
Smoking status: When stratified by smoking status, 
the increase lung cancer risk with younger age at 
menopause only remained significant among current 
smokers (P for trend = 0.001); there was no 
significant association between age at menopause 
and lung cancer among never and former smokers. 
Histological subtypes: Small cell carcinoma is 
inversely associated with age at menopause, 
whereas the relationship between age at menopause 
and adenocarcinoma or squamous carcinoma is not 
statistically significant. 
Brinton et al. 
(2011) 17 
Cohort                        
 Variable Type: Categorical;  
1) <45, 45-49, 50-54, and 
≥55 years 
Confounder Adjustment:   
Age, race/ethnicity, 
education, BMI, emphysema, 
smoking status and dose, 
age at menarche.          
185,017 women between the 
ages of 50 and71 years were 
recruited into the NIH-AARP 
(American Association of 
Retired Persons) Diet and 
Health Study during 1995 and 
1996. 
There was an 
inverse relationship 
between age at 
menopause and 
lung cancer risk (P 
for trend <0.0001). 
Smoking status & Type of Menopause: For women 
that had a natural menopause, age at menopause 
was inversely associated with lung cancer risk among 
current and former smokers (P for trend <0.01 and 
<0.0001). For women that had an unnatural 
menopause, age at menopause was inversely 
associated with lung cancer only among former 
smokers (P for trend <0.001).  
Histological Subtypes: Among women that had a 
natural menopause, the risk of adenocarcinoma and 
squamous cell carcinoma increase with younger age 
at menopause (P for trend < 0.01 and < 0.001, 
respectively). Among women that had an unnatural 
menopause, the risk of small cell carcinoma 
increased with younger age at menopause (P for 
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Meinhold et 
al. (2011) 18 
Case-Control            
 Variable Type: Categorical;  
1) Natural menopause <50, 
natural menopause 50-54, 
and natural menopause 
≥55years 
Confounder Adjustment:  
Age, education, smoking, 
number of smoking adults in 
household and current 
household income. 
430 women diagnosed with 
non-small cell lung cancer, 316 
hospital controls and 295 
population controls recruited in 
the multi-center Maryland Lung 
Cancer Study between 1998 
and 2008. 
There was no 
significant 
association 
between age at 
natural menopause 
and non-small cell 




Smoking status: The association between age at 
natural menopause and non-small cell lung cancer 
was not significant when stratified by smoking status. 
Lim et al. 
(2012) 16 
Case-Control  
Variable Type: Categorical; 
1) ≤48, 49-51 and  ≥52years 
Confounder Adjustment:  
Age, fruit and vegetable 
consumption, country of 
origin, dwelling type, years of 
education, history of cancer 
in first-degree relatives, 
smoking status , secondhand 
smoke exposure at home, 
and  study set. 
702 Chinese female lung 
cancer cases and 1,578 
hospital controls from 2 
hospital-based 
case-control studies, which 
recruited from the 5 major 
public-sector hospitals in 
Singapore during 1996–1998 
and 2005–2008. 
There was positive 
association 
between age at 
menopause and 
lung cancer (P for 
trend = 0.027). 
Smoking status: There was a positive association 
between age at menopause and lung cancer among 
never smoking status (P for trend = 0.003); however, 
this relationship was not significant among ever 
smokers.            
Gallagher et 
al. (2013) 15 
Cohort                         
Variable Type: Categorical;  
1) ≤48, 49-51 and ≥52 years 
Confounder Adjustment:  
Age and smoking.  
267,400 female textile workers 
in Shanghai, China, enrolled 
between 1989 and 1991 and 
followed until 2000 for 
incidence of lung cancer. 
There was no 
significant 
association 









APPENDIX D: Supplementary Table 3: Gravidity 
 
Authors Study Design Population Key Findings Effect Modifiers 
Koushik et al. 
(2009) 21 
Case-Control             
Variable Type: Categorical;         
1) Nulligravid, 1, 2, 3 and ≥4 
pregnancies            
Confounder Adjustment: 
Age, respondent status, 
ethnicity, education, family 
income, and smoking status. 
422 women with lung cancer 
and 577 population-based 
controls from Montreal, 
Canada recruited between 
January 1996 and December 
1997. 




and lung cancer. 
Histological subtypes: There is no significant 
association between gravidity and adenocarcinoma; 













APPENDIX E: Supplementary Table 4: Parity 
 
Authors Study Design Population Key Findings Effect Modifiers 
Kreuzer et al. 
(2003) 29 
Case-Control             
Variable Type: Categorical;          
1) 0, 1, 2-3 and ≥4 full-term 
pregnancies            
Confounder Adjustment:  
Age, region, pack years of 
smoking, smoking status, 
and education. 
811 women with lung cancer 
and 912 population controls 
enrolled between 1990 and 
1996 in Germany. 
There was no 
significant 
association 
between parity and 
lung cancer. 
Smoking status: There was no significant association 
between parity and lung cancer among strata based 
on smoking status (non-smokers and smokers). 
Histological subtypes: There was no significant 
association between parity and lung cancer among 
strata based on histology (adenocarcinoma, small cell 
carcinoma and squamous carcinoma). 
Brenner et al. 
(2003) 30 
Case-Control             
Variable Type: Categorical;          
1) 1-2, 3-4, 5-6, ≥7children            
Confounder Adjustment:  
Age and prefectures 
(Pingliang and Qingyang). 
109 incident female lung 
cancer cases and 435 
population-based frequency 
matched (on gender and age) 
controls recruited from 
hospitals in two rural 
prefectures (Pingliang and 
Qingyang) in Eastern Gansu 
Province, China, between 
January 1994 and April 1998. 
There is no 
significant 
association 
between parity and 
lung cancer. 
Not analyzed 
Elliott et al. 
(2006) 27 
Nested Case-Control             
Variable Type: Categorical;          
1) 0, 1, 2 and ≥3 children     
Confounder Adjustment:  
Smoking and social class. 
162 incident cases of lung 
cancer, among women,  
recorded by the Royal College 
of General Practitioners’ Oral 
Contraception Study 
(OCS)database by August 
2004, and age and length of 
follow-up matched  controls 
(n=3*162) from the same 
cohort. 
There was a 
positive association 
between parity and 
lung cancer (P for 
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Authors Study Design Population Key Findings Effect Modifiers 
Kabat et al. 
(2007) 25 
Cohort             
Variable Type: Categorical;          
1) Nulliparous and Parous  
2) Nulliparous, 1, 2, 3, 4 and 
≥5 children            
Confounder Adjustment:  
Body mass index, education, 
smoking status, pack-years 
of smoking, study center and 
randomization group 
(intervention versus control), 
and other exposure 
variables. 
89,835 Canadian women aged 
40–59 years recruitment in the 
Canadian National Breast 
Screening Study (NBSS), a 
randomized controlled trial of 
screening for breast cancer, 
between 1980 and 1985. 
There was no 
significant 
difference in the 
odds of lung cancer 
between 
nulliparous and 
parous women.  
However, when the 
parous was further 
divided into 1, 2, 3, 
4 and ≥5 children, 
the odds of lung 
cancer increased 
with the number of 
children (P for trend 
= 0.02). 
Smoking status: The odd of lung cancer increased 
with the number of children among never smokers (P 
for trend = 0.02); however, this association was not 
significant among ever smokers. 
Histological subtypes: There was no significant 
association between parity and lung cancer after 
stratifying by histology. 
Age: The association between parity and lung cancer 
was no longer significant after stratification by age 
(40-49 and 50-59 years). 
Weiss et al. 
(2008) 23 
Cohort                 
Variable Type: Categorical;          
1) 0, 1- 3 and ≥4 children    
Confounder Adjustment:  
Passive smoking 
71,314 non-smoking Chinese 
women aged 40-70 with no 
history of cancer at baseline 
from the prospective Shanghai 
Women’s Health Study 
conducted between 1996 and 
2000. 
As parity increases, 
the risk of lung 
cancer decreases 
(P for trend <0.01). 
Histological subtypes: The association between parity 
and lung cancer was not significant among women 
with adenocarcinoma; this relationship was not 
examined among women with other histologic types 
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Authors Study Design Population Key Findings Effect Modifiers 
Koushik et al. 
(2009) 21 
Case-Control             
Variable Type: Categorical;          
1) Nulliparous, 1, 2, 3 and ≥4 
children            
Confounder Adjustment:  
Age, respondent status, 
ethnicity, education, family 
income, and smoking status. 
422 women with lung cancer 
and 577 population-based 
controls from Montreal, 
Canada recruited between 
January 1996 and December 
1997. 
There was no 
significant 
association 
between parity and 
lung cancer. 
Histological subtypes: There was no significant 
association between parity and adenocarcinoma; 
other histological subtypes were not analyzed. 
Seow et al. 
(2009) 22 
Cohort                             
 Variable Type: Categorical;          
1) Measured as number of 
live births: 0, 1-2, 3-4 and ≥5                                 
Confounder Adjustment:   
Age, year of interview (1993-
1995, 1996-1998), dialect 
group (Cantonese, Hokkien), 
educational level, body mass 
index (BMI), total vegetable 
intake, total fruit/juice intake, 
β-cryptoxanthin, total 
isothiocyanates, and duration 
of 
smoking (years), cigarettes 
per day, and number of 
years since quitting among 
current or former smokers.          
35,298 women aged 45 to 78 
years recruited into the 
Singapore Chinese Health 
Study between April 1993 and 
December 1998. 
As the number of 
live births 
increased the risk 
of lung cancer 
decrease (P for 
trend = < 0.01). 
Smoking status: When stratified by smoking status, 
the association between parity and lung cancer was 
no longer significant.                                                 
Histological subtypes: Only divided into two 
categories, adenocarcinoma and other histological 
subtypes. Number of live births was inversely 
associated with adenocarcinoma risk (P for trend 
<0.01); however, no significant association was found 
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Paulus et al. 
(2010) 20 
Case-Control             
Variable Type: Categorical;          
1) Nulliparous and Parous  
2) Nulliparous, 1, 2, 3 and ≥4 
children            
Confounder Adjustment:  
Age, smoking status, pack-
years of smoking, and years 
since quitting smoking. 
1,004 cases and 848 controls 
(friends and non-blood 
relatives) enrolled in the Lung 
Cancer Susceptibility Study 
(LCSS) at Massachusetts 
General Hospital (Boston, 
Massachusetts) between 
December 1992 and 
December 2003. 





nulliparous women.                            
2) Lung cancer 
odds decrease with 
increasing number 
of children; the 
linear trend was 
significant.  
Smoking status: The inverse association between 
lung cancer and parity remained significant among 
never-smokers; however, the association was not 
statistically significant among ever-smokers.                                  
Age at diagnosis: The inverse association was 
statistically significant among women diagnosed at 
≥50 years of age, but not among those diagnosed 
before 50.                                                            
Histological subtypes: The relationship between lung 
cancer and parity were similar among all subgroups 
based on histology. 
Baik et al. 
(2010) 19 
Cohort                         
Variable Type: Categorical;          
1) Nulliparous and Parous  
2) 1-2, 3-4 and ≥5 children    
Confounder Adjustment:  
Smoking, fruit/vegetable in- 
take, BMI, environmental 
smoking exposure, and other 
exposure variables.  
107,171 postmenopausal 
women aged 30-55 years 
enrolled in the Nurse's Health 
Study, collected between 1984 
and 2006.  
The association 
between parity and 
lung cancer is not 
significant. 
Smoking status: Among parous women, increased 
number of children was associated with decreased 
lung cancer risk in never smokers (P for trend = 
0.03). However, this association was not significant 
among former and current smokers.   
Histological subtypes: There is an inverse 
relationship between parity and lung cancer among 
women with small cell carcinoma. This association is 
not significant among women with adenocarcinoma 
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Brinton et al. 
(2011) 17 
Cohort                        
Variable Type: Categorical;          
1) Nulliparous and Parous  
2) Nulliparous, 1, 2, 3-4 and  
≥5 children   
Confounder Adjustment:  
Age, race/ethnicity, 
education, BMI, emphysema, 
smoking status and dose, 
age at menarche, age at 
menopause and type of 
menopause.          
185,017 women between the 
ages of 50 and 71 years were 
recruited into the NIH-AARP 
(American Association of 
Retired Persons) Diet and 
Health Study during 1995 and 
1996. 
There was no 
significant 
association 




al. (2011) 18 
Case-Control             
Variable Type: Categorical;          
1) Nulliparous, 1-2, 3-4 and 
≥5 children            
Confounder Adjustment:  
Age, education, smoking, 
number of smoking adults in 
household and current 
household income. 
430 women diagnosed with 
non-small cell lung cancer, 316 
hospital controls and 295 
population controls recruited in 
the multi-center Maryland Lung 




associated with risk 
of non-small cell 
lung cancer, when 
comparing cases to 
hospital-controls, 
population-controls 
or both controls 
together (P for 
trend = 0.003, 0.01 
and 0.002, 
respectively). 
Smoking status: The association between parity and 
non-small cell lung cancer became insignificant when 
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Lim et al. 
(2012) 16 
Case-Control             
Variable Type: Categorical;          
1) 0, 1-2, 3-4 and  ≥5 
children            
Confounder Adjustment:  
Age, fruit and vegetable 
consumption, country of 
origin, dwelling type, years of 
education, history of cancer 
in first-degree relatives, 
smoking status, secondhand 
smoke exposure at home, 
and  study set. 
702 Chinese female lung 
cancer cases and 1,578 
hospital controls from 2 
hospital-based case-control 
studies, which recruited from 
the 5 major public-sector 
hospitals in Singapore during 
1996–1998 and 2005–2008. 
There was an 
inverse association 
between parity and 
lung cancer (P for 
trend = 0.001). 
Smoking status: The association between parity and 
lung cancer was no longer significant after stratifying 
by smoking status (never and ever smokers).       
Age: The inverse association remained significant 
among women older than 65 years (P for trend = 
0.001), but it was not significant among women 65 
and younger. 
Gallagher et 
al. (2013) 15 
Cohort                         
Variable Type: Categorical;  
1)0, 1, 2, 3, 4 and ≥5 children     
Confounder Adjustment:  
Age and smoking.  
267,400 female textile workers 
in Shanghai, China, enrolled 
between 1989 and 1991 and 
followed until 2000 for 
incidence of lung cancer. 
Women with 4 and 
5 or more children 
had a significant 
reduced risk of lung 
cancer compared 
to women without 
children; however, 
the p for trend 









APPENDIX F: Supplementary Table 5: Age at First Pregnancy 
 
Authors Study Design Population Key Findings Effect Modifiers 
Kreuzer et al. 
(2003) 29 
Case-Control             
Variable Type: Categorical;         
1) <22, 22-25 and ≥26 years       
Confounder Adjustment:  
Age, region, pack years of 
smoking, smoking status, 
and education. 
811 women with lung cancer 
and 912 population controls 
enrolled between 1990 and 
1996 in Germany. 
The odds of lung 
cancer decreased 
with older age at 
first pregnancy (P 
for trend = 0.007). 
Smoking status: The odds of lung cancer decreased 
with older age at first pregnancy among smokers; 
however, no significant association between age at 
first pregnancy with lung cancer was reported among 
non-smokers. 
Histological subtypes: The odds of lung cancer 
decreased with older age at first pregnancy for all 
histological subgroups (adenocarcinoma, small cell 
carcinoma and squamous carcinoma). 
Koushik et al. 
(2009) 21 
Case-Control             
Variable Type: Categorical;         
1) <22, 22-<25, 25-<29 and 
≥29years            
Confounder Adjustment:  
Age, respondent status, 
ethnicity, education, family 
income, and smoking status. 
422 women with lung cancer 
and 577 population-based 
controls from Montreal, 
Canada recruited between 
January 1996 and December 
1997. 
There was no 
significant 
association 
between age at first 
pregnancy and lung 
cancer. 
Histological subtypes: There was no significant 
association between age at first pregnancy and 











APPENDIX G: Supplementary Table 6: Age at First Birth 
 
Authors Study Design Population Key Findings Effect Modifiers 
Brenner et al. 
(2003) 30 
Case-Control             
Variable Type: Categorical;         
1) ≤18, 19-22 and ≥23years            
Confounder Adjustment:  
Age and prefectures 
(Pingliang and Qingyang). 
109 incident female lung 
cancer cases and 435 
population-based frequency 
matched (on gender and age) 
controls recruited from 
hospitals in two rural 
prefectures (Pingliang and 
Qingyang) in Eastern Gansu 
Province, China, between 
January 1994 and April 1998. 
There is no 
significant 
association 
between age at first 
birth and lung 
cancer. 
Not analyzed 
Kabat et al. 
(2007) 25 
Cohort             
Variable Type: Categorical;         
1) <23, 23-25, 26-29 and ≥30 
years           
Confounder Adjustment:  
Body mass index, education, 
smoking status, pack-years 
of smoking, study center and 
randomization group 
(intervention versus control), 
and other exposure 
variables. 
89,835 Canadian women aged 
40–59 years recruitment in the 
Canadian National Breast 
Screening Study (NBSS), a 
randomized controlled trial of 
screening for breast cancer, 
between 1980 and 1985. 
The odds of lung 
cancer decreased 
with older age at 
first birth (P for 
trend = 0.004). 
Smoking status: This inverse association remained 
significant after stratifying by never and ever smokers 
(P for trend = 0.01 and 0.02, respectively). 
Histological subtypes: The association between age 
at first birth and adenocarcinoma was not statistically 
significant; however, the odds of lung cancer of other 
cell types decreased with increasing age at first birth 
(P for trend = 0.004). 
Age: The inverse association between age at first 
birth and lung cancer remained significant after 
stratifying by age (P for trend (40-49 years) = 0.007 
and P for trend (50-59 years) = 0.07). 
Weiss et al. 
(2008) 23 
Cohort                         
Variable Type: Categorical;         
1) <23, 23-25, 26-27 and ≥28 
years     
Confounder Adjustment: 
Passive smoking. 
71,314 non-smoking Chinese 
women aged 40-70 with no 
history of cancer at baseline 
from the prospective Shanghai 
Women’s Health Study 
conducted between 1996 and 
2000. 
There was no 
significant 
association 
between age at first 
birth and lung 
cancer. 
Histological subtypes: There was no significant 
association between age at first birth and lung cancer 
among women with adenocarcinoma; this relationship 
was not examined among women with other 




APPENDIX G: Supplementary Table 6: Age at First Birth (Cont'd) 
 
Authors Study Design Population Key Findings Effect Modifiers 
Koushik et al. 
(2009) 21 
Case-Control             
Variable Type: Categorical;         
1) <23, 23-<26, 26-<30 and 
≥30 years            
Confounder Adjustment:  
Age, respondent status, 
ethnicity, education, family 
income, and smoking status. 
422 women with lung cancer 
and 577 population-based 
controls from Montreal, 
Canada recruited between 
January 1996 and December 
1997. 
There was no 
significant 
association 
between age at first 
birth and lung 
cancer. 
Histological subtypes: There was no significant 
association between age at first birth and 
adenocarcinoma; other histological subtypes were 
not analyzed. 
Paulus et al. 
(2010) 20 
Case-Control              
Variable Type: Categorical;         
1) <20, 20-24, 25-29 and ≥30 
years                             
Confounder Adjustment:  
Age, smoking status, pack-
years of smoking, and years 
since quitting smoking.           
1,004 cases and 848 controls 
(friends and non-blood 
relatives) enrolled in the Lung 
Cancer Susceptibility Study 
(LCSS) at Massachusetts 
General Hospital (Boston, 
Massachusetts) between 
December 1992 and 
December 2003. 
1) Lung cancer risk 
was not associated 
with age at first 
birth, among 
parous women.                             
Not analyzed 
Baik et al. 
(2010) 19 
Cohort                         
Variable Type: Categorical;         
1) <26, 26-30 and ≥30 years                        
Confounder Adjustment: 
Smoking, fruit/vegetable in- 
take, BMI, environmental 
smoking exposure, and other 
exposure variables  
107,171 postmenopausal 
women aged 30-55 years 
enrolled in the Nurse's Health 
Study, collected between 1984 
and 2006. 
There was no 
significant 
association 
between age at first 
birth and lung 
cancer. 
Smoking status: Age at first birth was positively 
associated with lung cancer among current smokers 
(P for trend=0.02). However, this association was not 
significant among never and former smokers. 
Histological subtypes: There is no significant 
association between age at first birth and lung 






APPENDIX G: Supplementary Table 6: Age at First Birth (Cont'd) 
 
Authors Study Design Population Key Findings Effect Modifiers 
Brinton et al. 
(2011) 17 
Cohort                        
 Variable Type: Categorical;         
1) <20, 20-24, 25-29 and ≥30 
years              
Confounder Adjustment:   
Age, race/ethnicity, 
education, BMI, emphysema, 
smoking status and dose, 
age at menarche, age at 
menopause and type of 
menopause.          
185,017 women between the 
ages of 50 and71 years were 
recruited into the NIH-AARP 
(American Association of 
Retired Persons) Diet and 
Health Study during 1995 and 
1996. 
There was an 
inverse relationship 
between age at first 
birth and lung 
cancer risk among 
parous women (P 
for trend = 0.03). 
Smoking status: The inverse relationship between 
age at first birth and lung cancer was only observed 
among current smoker (P for trend = 0.04), after 
stratifying my smoking status; this association was 
not statistically significant among never and former 
smokers.  
Histological subtypes: The association between age 
at first birth and lung cancer was not significant after 
stratifying by histological subgroups. 
Meinhold et 
al. (2011) 18 
Case-Control             
Variable Type: Categorical;         
1) <20, 20-24, ≥25 years           
Confounder Adjustment:  
Age, education, smoking, 
number of smoking adults in 
household and current 
household income. 
430 women diagnosed with 
non-small cell lung cancer, 316 
hospital controls and 295 
population controls recruited in 
the multi-center Maryland Lung 
Cancer Study between 1998 
and 2008. 
There was no 
significant 
association 
between age at first 
birth and non-small 





Smoking status: The association between age at first 
birth and non-small cell lung cancer was not 








APPENDIX G: Supplementary Table 6: Age at First Birth (Cont'd) 
 
Authors Study Design Population Key Findings Effect Modifiers 
Lim et al. 
(2012) 16 
Case-Control 
Variable Type: Categorical;  
1) 20, 21-25, 26-30 and  
≥31years  
Confounder Adjustment:  
Age, fruit and vegetable 
consumption, country of 
origin, dwelling type, years of 
education, history of cancer 
in first-degree relatives, 
smoking status , secondhand 
smoke exposure at home, 
and  study set. 
702 Chinese female lung 
cancer cases and 1,578 
hospital controls from 2 
hospital-based 
case-control studies, which 
recruited from the 5 major 
public-sector hospitals in 
Singapore during 1996–1998 
and 2005–2008. 
There was no 
significant 
association 
between age at first 
birth and lung 
cancer. 
Smoking status: There was no significant association 
between age at first birth and lung cancer by smoking 
status (never and ever smokers).            
Gallagher et 
al. (2013) 15 
Cohort                         
Variable Type: Categorical; 
1)<19, 20-24, 25-29 and  ≥30  
years   
Confounder Adjustment:  
Age and smoking.  
267,400 female textile workers 
in Shanghai, China, enrolled 
between 1989 and 1991 and 
followed until 2000 for 
incidence of lung cancer. 
There was no 
significant 
association 
between age at first 











APPENDIX H: Supplementary Table 7: Oral Contraceptive (OC) use 
 
Authors Study Design Population Key Findings Effect Modifiers 
Kreuzer et al. 
(2003) 29 
Case-Control             
Variable Type: Categorical;         
1) Never and ever       
Confounder Adjustment:  
Age, region, pack years of 
smoking, smoking status, 
and education. 
811 women with lung cancer 
and 912 population controls 
enrolled between 1990 and 
1996 in Germany. 
There was a 
decreased odds of 
lung cancer among 
ever OC users 
compared to never 
users. 
Smoking status: Among smokers, the odds of lung 
cancer was reduced among women that ever used 
OC compared to those at never used OC. However, 
no significant association between OC use and lung 
cancer was report among non-smokers. 
Histological subtypes: There was a significant 
reduction in the odds of small cell lung cancer and 
squamous cell carcinoma among OC ever users 
compared to never users; however the association 
between adenocarcinoma and OC use was not 
statistically significant. 
Elliott et al. 
(2006) 27 
Nested Case-Control             
Variable Type: Categorical;         
1) Never and ever  
2) Never, current and former     
Confounder Adjustment: 
Smoking, social class and 
parity. 
162 incident cases of lung 
cancer, among women,  
recorded by the Royal College 
of General Practitioners’ Oral 
Contraception Study 
(OCS)database by August 
2004, and age and length of 
follow-up matched  controls 
(n=3*162) from the same 
cohort. 
There was no 
significant 
association 
between OC use 










APPENDIX H: Supplementary Table 7: Oral Contraceptive (OC) use (Cont'd) 
 
Authors Study Design Population Key Findings Effect Modifiers 
Kabat et al. 
(2007) 25 
Cohort           
Variable Type: Categorical;         
1) Never and ever          
Confounder Adjustment:  
Body mass index, education, 
smoking status, pack-years 
of smoking, study center and 
randomization group 
(intervention versus control), 
and other exposure 
variables. 
89,835 Canadian women aged 
40–59 years recruitment in the 
Canadian National Breast 
Screening Study (NBSS), a 
randomized controlled trial of 
screening for breast cancer, 
between 1980 and 1985. 
The association 
between OC use 
and lung cancer 
was not statistically 
significant. 
Smoking status: There was no significant association 
between OC use and lung cancer after stratifying by 
smoking status (never and ever). 
Histological subtypes: There was no significant 
association between OC use and lung cancer after 
stratifying by histology (Adenocarcinoma and other 
cell types). 
Age: There was no significant association between 
OC use and lung cancer after stratifying by age (40-
49 and 50-59 years). 
Weiss et al. 
(2008) 23 
Cohort                         
Variable Type: Categorical;  
1) Never and ever 
Confounder Adjustment: 
Passive smoking. 
71,314 non-smoking Chinese 
women aged 40-70 with no 
history of cancer at baseline 
from the prospective Shanghai 
Women’s Health Study 
conducted between 1996 and 
2000. 
There was no 
significant 
association 
between OC use 
and lung cancer. 
Histological subtypes: There was no significant 
association between OC use and lung cancer among 
women with adenocarcinoma; this relationship was 
not examined among women with other histologic 









APPENDIX H: Supplementary Table 7: Oral Contraceptive (OC) use (Cont'd) 
 
Authors Study Design Population Key Findings Effect Modifiers 
Seow et al. 
(2009) 22 
Cohort 
Variable Type: Categorical; 
1) Never, <10years and 
≥10years 
Confounder Adjustment:   
Age, year of interview (1993-
1995, 1996-1998), dialect 
group (Cantonese, Hokkien), 
educational level, body mass 
index (BMI), total vegetable 
intake, total fruit/juice intake, 
β-cryptoxanthin, total 
isothiocyanates, and duration 
of smoking (years), 
cigarettes per day, and 
number of years since 
quitting among current or 
former smokers.          
35,298 women aged 45 to 78 
years recruited into the 
Singapore Chinese Health 
Study between April 1993 and 
December 1998. 
There was no 
significant 
association 
between OC use 
and lung cancer. 
Histological subtypes: There was no significant 
association between OC use and lung cancer, when 
stratified by histology. 
Baik et al. 
(2010) 19 
Cohort  
Variable Type: Categorical;  
1) Never and Ever 
Confounder Adjustment: 
Smoking, fruit/vegetable in- 
take, BMI, environmental 
smoking exposure, and other 
exposure variables. 
107,171 postmenopausal 
women aged 30-55 years 
enrolled in the Nurse's Health 
Study, collected between 1984 
and 2006. 
There was no 
significant 
association 
between OC use 
and lung cancer. 
Smoking status: The association between OC use 
and lung cancer remained insignificant when stratified 
by smoking status. 
Histological subtypes: There was no significant 
association between OC use and lung cancer when 






APPENDIX H: Supplementary Table 7: Oral Contraceptive (OC) use (Cont'd) 
 
Authors Study Design Population Key Findings Effect Modifiers 
Brinton et al. 
(2011) 17 
Cohort  
Variable Type: Categorical; 
1) Never used/use <1 year 
and Use  ≥ 1 year 
Confounder Adjustment:   
Age, race/ethnicity, 
education, BMI, emphysema, 
smoking status and dose, 
age at menarche, age at 
menopause and type of 
menopause.          
185,017 women between the 
ages of 50 and71 years were 
recruited into the NIH-AARP 
(American Association of 
Retired Persons) Diet and 
Health Study during 1995 and 
1996. 
There was no 
significant 
association 
between OC use 
and lung cancer. 
Not analyzed 
Meinhold et 
al. (2011) 18 
Case-Control 
Variable Type: Categorical; 
1)Never and ever 
Confounder Adjustment:  
Age, education, smoking, 
number of smoking adults in 
household and current 
household income. 
430 women diagnosed with 
non-small cell lung cancer, 316 
hospital controls and 295 
population controls recruited in 
the multi-center Maryland Lung 
Cancer Study between 1998 
and 2008. 
There was no 
significant 
association 
between OC use 
and non-small cell 




Smoking status: The association between OC use 
and non-small cell lung cancer was not significant 









APPENDIX H: Supplementary Table 7: Oral Contraceptive (OC) use (Cont'd) 
 
Authors Study Design Population Key Findings Effect Modifiers 
Lim et al. 
(2012) 16 
Case-Control 
Variable Type: Categorical; 
1) exogenous hormone use 
(combined OC and 
menopausal hormone use): 
Never, ≤5 years and ≥5years 
Confounder Adjustment:  
Age, fruit and vegetable 
consumption, country of 
origin, dwelling type, years of 
education, history of cancer 
in first-degree relatives, 
smoking status , secondhand 
smoke exposure at home, 
and  study set. 
702 Chinese female lung 
cancer cases and 1,578 
hospital controls from 2 
hospital-based 
case-control studies, which 
recruited from the 5 major 
public-sector hospitals in 
Singapore during 1996–1998 
and 2005–2008. 





hormone use and 
lung cancer. 
Smoking status: There was no significant association 
between exogenous hormone use and lung cancer by 








APPENDIX I: Supplementary Table 8: Duration of Oral Contraceptive (OC) use 
 
Authors Study Design Population Key Findings Effect Modifiers 
Kreuzer et al. 
(2003) 29 
Case-Control             
Variable Type: Categorical;         
1) Non-user, <5, 5-11 and 
≥12 years    
Confounder Adjustment:  
Age, region, pack years of 
smoking, smoking status, 
and education. 
811 women with lung cancer 
and 912 population controls 
enrolled between 1990 and 
1996 in Germany. 
There was no 
significant 
association 
between duration of 
OC use and lung 
cancer. 
Smoking status: There was no significant association 
between duration of OC use and lung cancer after 
stratifying by smoking status (non-smokers and 
smokers). 
Histological subtypes: There was no significant 
association between duration of OC use and lung 
cancer after stratifying by histology (adenocarcinoma, 
small cell carcinoma and squamous carcinoma). 
Elliott et al. 
(2006) 27 
Nested Case-Control             
Variable Type: Categorical;         
1) No use, <5, 5-9 and 
≥10years    
Confounder Adjustment: 
Smoking, social class and 
parity. 
162 incident cases of lung 
cancer, among women,  
recorded by the Royal College 
of General Practitioners’ Oral 
Contraception Study 
(OCS)database by August 
2004, and age and length of 
follow-up matched  controls 
(n=3*162) from the same 
cohort. 
There was no 
significant 
association 
between duration of 
OC use and lung 
cancer. 
Not analyzed 
Kabat et al. 
(2007) 25 
Cohort          
Variable Type: Categorical;         
1) Never, 1-11, 12-35, 36-71 
and ≥72 months          
Confounder Adjustment:  
Body mass index, education, 
smoking status, pack-years 
of smoking, study center and 
randomization group 
(intervention versus control), 
and other exposure 
variables. 
89,835 Canadian women aged 
40–59 years recruitment in the 
Canadian National Breast 
Screening Study (NBSS), a 
randomized controlled trial of 
screening for breast cancer, 
between 1980 and 1985. 
The association 
between duration of 
OC use and lung 
cancer was not 
statistically 
significant. 
Smoking status: There was no significant association 
between duration of OC use and lung cancer after 
stratifying by smoking status (never and ever). 
Histological subtypes: There was no significant 
association between duration of OC use and lung 
cancer after stratifying by histology (Adenocarcinoma 
and other cell types). 
Age: There was no significant association between 
duration of OC use and lung cancer after stratifying 




APPENDIX I: Supplementary Table 8: Duration of Oral Contraceptive (OC) use (Cont'd) 
 
Authors Study Design Population Key Findings Effect Modifiers 
Seow et al. 
(2009) 22 
Cohort                             
Variable Type: Categorical;         
1) Never, <10years and 
≥10years                                 
Confounder Adjustment:   
Age, year of interview (1993-
1995, 1996-1998), dialect 
group (Cantonese, Hokkien), 
educational level, body mass 
index (BMI), total vegetable 
intake, total fruit/juice intake, 
β-cryptoxanthin, total 
isothiocyanates, and duration 
of smoking (years), 
cigarettes per day, and 
number of years since 
quitting among current or 
former smokers.          
35,298 women aged 45 to 78 
years recruited into the 
Singapore Chinese Health 
Study between April 1993 and 
December 1998. 
There was no 
significant 
association 
between OC use 
and lung cancer. 
Histological subtypes: There was no significant 
association between OC use and lung cancer, when 
stratified by histology. 
Baik et al. 
(2010) 19 
Cohort                         
Variable Type: Categorical;         
1) <5 and >5 years                   
Confounder Adjustment: 
Smoking, fruit/vegetable in- 
take, BMI, environmental 
smoking exposure, and other 
exposure variables. 
107,171 postmenopausal 
women aged 30-55 years 
enrolled in the Nurse's Health 
Study, collected between 1984 
and 2006. 
Women that used 
oral contraceptives 
for more than 5 
years had and 
increased risk of 
lung cancer 
compared those 
that used OC for 
less than 5 years. 
Smoking status: When stratified by smoking status, 
the increased lung cancer risk among women that 
use oral contraceptives for more than 5 years was 
observed among current smoker, but the relationship 
was not statistically significant among never and 
former smokers.  
Histological subtypes: When stratified by histological 
subtypes, there was an increased risk of small cell 
carcinoma with greater than 5 years of OC use. 
However, there was no significant association 
between adenocarcinoma or squamous carcinoma 





APPENDIX I: Supplementary Table 8: Duration of Oral Contraceptive (OC) use (Cont'd) 
 
Authors Study Design Population Key Findings Effect Modifiers 
Brinton et al. 
(2011) 17  
Cohort                        
 Variable Type: Categorical;         
1) Never used/use <1 year, 
1-4, 5-9, ≥10 years             
Confounder Adjustment:   
Age, race/ethnicity, 
education, BMI, emphysema, 
smoking status and dose, 
age at menarche, age at 
menopause and type of 
menopause.          
185,017 women between the 
ages of 50 and 71 years were 
recruited into the NIH-AARP 
(American Association of 
Retired Persons) Diet and 
Health Study during 1995 and 
1996. 
There was no 
significant 
association 
between duration of 




al. (2011) 18 
Case-Control             
Variable Type: Categorical;         
1) <5years and ≥5years   
Confounder Adjustment:  
Age, education, smoking, 
number of smoking adults in 
household and current 
household income. 
430 women diagnosed with 
non-small cell lung cancer, 316 
hospital controls and 295 
population controls recruited in 
the multi-center Maryland Lung 
Cancer Study between 1998 
and 2008. 
There was no 
significant 
association 
between duration of 
OC use and non-
small cell lung 









APPENDIX I: Supplementary Table 8: Duration of Oral Contraceptive (OC) use (Cont'd) 
 
Authors Study Design Population Key Findings Effect Modifiers 
Lim et al. 
(2012) 16 
Case-Control 
Variable Type: Categorical; 
1) exogenous hormone use 
(combined OC and 
menopausal hormone use): 
Never, ≤5 years and ≥5 
years 
Confounder Adjustment:  
Age, fruit and vegetable 
consumption, country of 
origin, dwelling type, years of 
education, history of cancer 
in first-degree relatives, 
smoking status , secondhand 
smoke exposure at home, 
and  study set. 
702 Chinese female lung 
cancer cases and 1,578 
hospital controls from 2 
hospital-based 
case-control studies, which 
recruited from the 5 major 
public-sector hospitals in 
Singapore during 1996–1998 
and 2005–2008. 





hormone use and 
lung cancer. 
Smoking status: There was no significant association 
between exogenous hormone use and lung cancer by 







APPENDIX J: Supplementary Table 9: Post-Menopausal Hormone use 
 
Authors Study Design Population Key Findings Effect Modifiers 
Kreuzer et al. 
(2003) 29 
Case-Control             
Variable Type: Categorical;         
1) Never and ever 
2) Nonusers, <3, 3-6 and 
≥7years      
3) Use after surgical 
menopause: ever, never, <3, 
3-6, ≥7 years  
Confounder Adjustment:  
Age, region, pack years of 
smoking, smoking status, 
and education. 
811 women with lung 
cancer and 912 
population controls 
enrolled between 1990 
and 1996 in Germany. 
There was no significant 
association between 
menopausal hormone use 
and lung cancer. However, 
the odds of lung cancer 
decrease among women 
that used menopausal 
hormone  for 7 years or 
more, compared to never 
users  (OR=0.59; 95% 
CI=0.37-0.93). Among 
women that use 
menopausal hormone after 
surgical menopause, 
reduced odds of lung 
cancer was also observed 
with increased duration of 
menopausal hormone use. 
Smoking status: There was no significant association 
between menopausal hormone use and lung cancer 
among smokers and non-smokers that had surgical 
menopause. 
Histological subtypes: There was no significant 
association between menopausal hormone use and 
lung cancer women that had surgical menopause, 





APPENDIX J: Supplementary Table 9: Post-Menopausal Hormone use (Cont'd) 
 
Authors Study Design Population Key Findings Effect Modifiers 
Elliott et al. 
(2006) 27 
Nested Case-Control             
Variable Type: Categorical;         
1) Never and ever  
2) Never, current and former     
Confounder Adjustment: 
Smoking, social class and 
parity. 
162 incident cases of 
lung cancer, among 
women,  recorded by 





August 2004, and age 
and length of follow-up 
matched  controls 
(n=3*162) from the 
same cohort. 
There was no significant 
association between 
menopausal hormone use 
and lung cancer. 
Not analyzed 
Chen et al. 
(2007) 26 
Case-Control                             
Variable Type: Categorical;         
1) Yes and No                               
Confounder Adjustment:   
Age, ethnicity, smoking, 
education, BMI, menopause, 
cooking, motorcycle riding, 
passive smoking, incense 
burning, family history.          
826 lung cancer cases 
and 531 healthy 
controls enrolled in the 
Genetic 
Epidemiological Study 
of Female Lung 
Adenocarcinoma  
(GEFLAC) in Taiwan 
form September 2002 
to February 2006. 
Women that receive 
hormone replacement 
therapy had reduced odds 
of lung cancer. 
Smoking status: The odds of lung cancer reduced 
with hormone replacement therapy use among 
female never smoker; however, this association was 
not significant among ever smokers. 
Histological subtypes: The odds of non-small cell 
carcinoma and large cell lung cancer were lower 
among hormone replacement therapy (HRT) users; 
however, the associations between HRT and 
adenocarcinoma, squamous cell carcinoma and small 
cell lung cancer were not significant. 
* This study also investigated effect modification by 
active and passive cigarette smoking, BMI, history of 
incense burning, 
cooking, and motorcycle riding, as well as family 
history of cancer. Reduced odds ratios of lung cancer 





APPENDIX J: Supplementary Table 9: Post-Menopausal Hormone use (Cont'd) 
 
Authors Study Design Population Key Findings Effect Modifiers 
Kabat et al. 
(2007) 25 
Cohort        
Variable Type: Categorical;         
1) Never and ever  
2) Never, 1-12, 13-59, 60-
119 and ≥120 months        
Confounder Adjustment:  
Body mass index, education, 
smoking status, pack-years 
of smoking, study center and 
randomization group 
(intervention versus control), 
and other exposure 
variables. 
89,835 Canadian 
women aged 40–59 
years recruitment in the 
Canadian National 
Breast Screening 
Study (NBSS), a 
randomized controlled 
trial of screening for 
breast cancer, between 
1980 and 1985. 
There was not significant 
difference between women 
that never used 
menopausal hormones and 
those that ever used 
menopausal hormone. 
However, the risk of lung 
cancer increase among 
women that used 
menopausal hormone for 
120months or more, 
compared to never users 
(HR=1.51; 95% CI=1.14-
1.99). 
Smoking status: There was no significant association 
between menopausal hormone use (of duration of 
use) and lung cancer after stratifying by smoking 
status (never and ever). 
Histological subtypes: There was no significant 
association between menopausal hormone use (of 
duration of use) and lung cancer after stratifying by 
histology (Adenocarcinoma and other cell types). 
Age: When only women between the age of 50-
59years were analyzed, there was an inverse 
association between duration of menopausal 
hormone use and lung cancer (P for trend = 0.01); 
nevertheless, there was no significant difference 
between never and ever users of menopausal 
hormone. 
Weiss et al. 
(2008) 23 
Cohort                        
 Variable Type: Categorical;  




Chinese women aged 
40-70 with no history of 
cancer at baseline from 
the prospective 
Shanghai 
Women’s Health Study 
conducted between 
1996 and 2000. 
There was no significant 
association between 
menopausal hormone use 
and lung cancer. 
Histological subtypes: There was no significant 
association between menopausal hormone use and 
lung cancer among women with adenocarcinoma; 
this relationship was not examined among women 






APPENDIX J: Supplementary Table 9: Post-Menopausal Hormone use (Cont'd) 
 
Authors Study Design Population Key Findings Effect Modifiers 
Rodriguez et 
al. (2008) 24 
Cohort                             
Variable Type: Categorical;         
1) Never, current and former                             
Confounder Adjustment:   
Age, smoking status, spousal 
tobacco exposure in 1992, 
body mass index in 1992, 
age at menopause, 
education, weekly servings 
of fruit, physical activity, total 
β-carotene intake, and oral 
contraceptive use.          
97,786 female 
participants of the 
Cancer Prevention 
Study II (CPS-II) 
Nutrition Cohort 
followed-up from 1992 
to 2003. 
There was an increased 
risk of lung cancer among 
current users of 
menopausal hormones 
compared to never users. 
Smoking status: There was no significant association 
between menopausal hormone use and lung cancer 
after stratification by smoking status (never, current 
and former). 
Seow et al. 
(2009) 22 
Cohort                             
Variable Type: Categorical;         
1) Yes and No                               
Confounder Adjustment:   
Age, year of interview (1993-
1995, 1996-1998), dialect 
group (Cantonese, Hokkien), 
educational level, body mass 
index (BMI), total vegetable 
intake, total fruit/juice intake, 
β-cryptoxanthin, total 
isothiocyanates, and duration 
of smoking (years), 
cigarettes per day, and 
number of years since 
quitting among current or 
former smokers.          
35,298 women aged 45 
to 78 years recruited 
into the Singapore 
Chinese Health Study 
between April 1993 
and December 1998. 
There was no significant 
association between 
menopausal hormone use 
and lung cancer. 
Histological subtypes: There was no significant 
association between menopausal hormone use and 
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Authors Study Design Population Key Findings Effect Modifiers 
Baik et al. 
(2010) 19 
Cohort                           
Variable Type: Categorical;         
1) Never, past and current                  
Confounder Adjustment: 
Smoking, fruit/vegetable in- 
take, BMI, environmental 




women aged 30-55 
years enrolled in the 
Nurse's Health Study, 
collected between 
1984 and 2006.  
There was no significant 
association between 
menopausal hormone use 
and lung cancer. 
Smoking status: There was no significant association 
between menopausal hormone use and lung cancer, 
among the strata formed by smoking status.    
Histological subtypes: The association between 
menopausal hormone use and lung cancer were not 
significant when stratified by histology. 
Brinton et al. 
(2011) 17 
Cohort                        
 Variable Type: Categorical;         
1) Never, Current, Former             
Confounder Adjustment:   
Age, race/ethnicity, 
education, BMI, emphysema, 
smoking status and dose, 
age at menarche.          
185,017 women 
between the ages of 50 
and 71 years were 
recruited into the NIH-
AARP (American 
Association of Retired 
Persons) Diet and 
Health Study during 
1995 and 1996. 
There was no significant 
association between 
menopausal hormone use 
and lung cancer. 
Not analyzed 
Meinhold et 
al. (2011) 18 
Case-Control             
Variable Type: Categorical;         
1) Never and ever               
2) <5years and ≥5years of 
use                                              
3) <5years and ≥5years 
since last use                              
Confounder Adjustment:  
Age, education, smoking, 
number of smoking adults in 
household and current 
household income. 
430 women diagnosed 
with non-small cell lung 
cancer, 316 hospital 
controls and 295 
population controls 
recruited in the multi-
center Maryland Lung 
Cancer Study between 
1998 and 2008. 
There was no significant 
association between 
menopausal hormone use 
and non-small cell lung 
cancer, when using 
hospital, population or 
combined controls. 
Smoking status: The association between 
menopausal hormone use and non-small cell lung 






APPENDIX J: Supplementary Table 9: Post-Menopausal Hormone use (Cont'd) 
 
Authors Study Design Population Key Findings Effect Modifiers 
Lim et al. 
(2012) 16 
Case-Control 
Variable Type: Categorical; 
1) exogenous hormone use 
(combined OC and 
menopausal hormone use): 
Never, ≤5 years and ≥5 
years                    
Confounder Adjustment:  
Age, fruit and vegetable 
consumption, country of 
origin, dwelling type, years of 
education, history of cancer 
in first-degree relatives, 
smoking status, secondhand 
smoke exposure at home, 
and  study set. 
702 Chinese female 
lung cancer cases and 
1,578 hospital controls 
from 2 hospital-based 
case-control studies, 
which recruited from 
the 5 major public-




There was no significant 
association between 
exogenous hormone use 
and lung cancer. 
Smoking status: There was no significant association 
between exogenous hormone use and lung cancer by 
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